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Chronic stress and other emotional factors may have relevant impacts on pregnancy 
outcomes because they are related to neuroendocrine changes that lead to alterations in 
immunomodulation during pregnancy. In this quantitative prospective cross-sectional study, 
the relationship of emotional lability, depression, and stress during pregnancy and the 
development of preterm labor, preeclampsia, placental abruption, and low birth weight for 
gestational age babies was examined. Additionally, social support scores were compared to 
levels of stress/anxiety, depression, and emotional lability in pregnant women. Two hundred 
and forty two pregnant women who received prenatal services at the National Institute of 
Perinatology in Mexico City were evaluated during the 2nd or 3rd trimester of pregnancy and 
followed until pregnancy termination. Logistic regression analyses showed that being single 
significantly predicted preeclampsia and preterm birth, and the presence of social support 
significantly decreased the likelihood of preterm birth development.  In the logistic 
regression model, family income significantly predicted the development of abruptio 
placentae. MANCOVA results revealed a significant difference among the social support 
categories on the combined dependent variables (stress/anxiety, depression, and emotional 
lability). The ANCOVA reported significant differences between social support scores, and 
stress/anxiety and depression scores. ANCOVA also showed significant differences between 
the number of pregnancies and stress scores. A 2X2 factorial analysis of variance showed a 
significant main effect of stress and depression on newborn weight. By promoting awareness 
of the importance of emotional factors during pregnancy among healthcare workers and 
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Chapter 1: Introduction to the Study  
Introduction 
The concept that emotional factors may regulate biological responses is not a new 
one. Since the 1800s, medical professionals have reported the development of diseases in 
individuals experiencing terrible fear, without finding explanations for fatal outcomes 
(Risse, 1988). Among many researchers, the idea that emotions could have an effect on 
health was seen as folklore (Angell, 1985). Cannon (1957) was one of the first to point 
out the importance of social environments in biological systems. He identified the effects 
of rage and fear on the nervous system, especially in the activation of the sympathetic 
nervous system (Cannon, 1942). Years of research on the mechanisms that participate in 
the stress response have helped scholars understand the multiple biological consequences 
of this response and the emotional factors that may participate as triggers. Researchers 
now know that the sympathetic nervous system participates in conjunction with the 
hypothalamus-pituitary-adrenal axis in the stress response (Glei, Goldman, Chuang, & 
Weinstein, 2007). Knowledge regarding the activation and the regulatory mechanisms 
that participate in the response to stress has increased in recent years as well (McEwen, 
2005).  
One of the most relevant leaps into the understanding of emotional factors as 
promoters of disease development was made by Ader (1975) in his 
psychoneuroimmunological theory. He was the cofounder of the 
psychoneuroimmunology field and the first to contradict the principle that the immune 




suppress immune responses. He revealed the connections between the central nervous 
system and the immune system (Pincock, 2012).  
Psychoneuroimmunological concepts may be useful in several areas of medical 
practice, such as endocrinology, rheumatology, infectology, and neurology. Nevertheless, 
psychoneuroimmunology is especially important in the reproductive area, particularly 
during pregnancy, when the immune system is finely regulated in order to promote 
maternal acceptance of the fetus. Emotional phenomena during pregnancy may lead to 
neuroendocrine changes that can alter this delicate regulation and lead to the development 
of disease.  
Several researchers have associated the role of stress and anxiety with the 
development of preterm labor (Holzman et al., 2009; Rondo et al., 2003), but its 
relationship with other psychosocial factors such as depression and emotional lability has 
not been fully explored. Moreover, the association of depression and emotional lability 
with the development of other pregnancy complications such as preeclampsia and 
abruptio placentae has not been clearly established.  The identification of psychosocial 
risk factors for pregnancy complications may have positive implications for social change 
because psychosocial phenomena represent modifiable risk factors in pregnancy. By 
reducing risks for pregnancy complications, professionals can promote the birth of 
healthy babies. 
Background 
Pregnancy is a delicate period in terms of immunorregulation. The mother’s 




permits the existence of the fetus within the mother’s body. Because the immune system 
is highly connected with neuroendocrine systems, it may be affected by increases in 
catecholamines or stress hormones (Bierhaus et al., 2003). The delicate regulation of the 
immune system during pregnancy may therefore be disrupted in the presence of chronic 
stress or other emotional factors that activate neuroendocrine responses. The 
psychoneuroimmunology of pregnancy has not been fully explored. While the role of 
stress and anxiety on the development of preterm labor is a well-known phenomenon 
(Dole et al., 2003; Kramer et al., 2009), the participation of emotional lability and 
depression in the origins of other pregnancy complications and the role of social support 
in the pregnant woman’s emotional life have not been clarified yet. 
Problem Statement 
Existing research has shown that emotional factors may increase the risk of 
developing pregnancy complications (Roy-Matton, Moutquin, Brown, Carrier, & Bell, 
2011). Stress, depression, and anxiety have been related to preterm labor (Dayan et al., 
2002; Rondo et al., 2003).  However, there is a knowledge gap regarding the effect of 
stress, depression, and emotional lability on the development of pregnancy complications 
different from preterm labor. The goal of this study was to further understand the 
participation of stress and anxiety in the development of pregnancy complications and to 
determine whether other emotional factors, such as emotional lability and depression, 
may be related to other adverse pregnancy outcomes. 
The psychosocial environment of the pregnant woman, especially the availability 




perceives stressful situations. In order to better understand the role of social support on 
emotional phenomena during pregnancy, this study compared the amount of perceived 
social support to the presence of anxiety or depressive symptoms and to emotional 
lability. Lack of social support may also increase vulnerability to stress/anxiety, 
depression, or emotional lability in the pregnant woman.  
Low birth weight in offspring has also been related to maternal stress and to 
stress-induced dysregulation of the hypothalamic-pituitary-adrenal axis (Khashan et al., 
2008). However, there is still a need to determine whether depressive symptoms or 
emotional lability may increase the risk of delivering a baby below the 10th percentile in 
weight.  
Deductive research was performed in this study, in which 
psychoneuroimmunological and somatization theories were tested (Brown, 2007); all of 
these theories applied to stress/anxiety, emotional lability, and depression during the 
gestational period.  
Purpose of the Study 
The objective of this study was to quantitatively evaluate the effect of 
stress/anxiety, emotional lability, and depression during the first trimester of pregnancy 
on the development of any of the following pregnancy complications—preeclampsia, 
abruptio placentae, and preterm delivery—and on newborn outcomes, controlling for the 





This study was also designed to determine whether birthweight was lower in the 
offspring of mothers with higher levels of stress/anxiety or emotional liability during  
pregnancy. Additionally, the study explored the issue of whether the amount of perceived 
social support may influence levels of stress/anxiety and/or emotional liability in 
pregnant women. 
Research Questions and Hypotheses 
The following research questions were derived from the review of previous 
literature in the area of stress, anxiety, depression, social support, and pregnancy 
complications. 
Research Question 1 
Is there a significant relationship between the presence of stress/anxiety, 
depression, and/or emotional lability, and the development of preeclampsia, abruptio 
placentae, preterm labor, and low birthweight for gestational age babies? 
Hypothesis 1 
Null Hypothesis (H0): There is no significant relationship between stress/anxiety, 
depression, and emotional lability scores and the development of preeclampsia, abruptio 
placentae, preterm labor, and low birthweight for gestational age babies. 
Alternative Hypothesis (H1): There is a significant relationship between 
stress/anxiety, depression, and emotional lability scores and the development of 





Research Question 2 
Does the availability or unavailability of social support during pregnancy have a 
relationship with the presence of stress/anxiety, emotional lability, and/or depression? 
Hypothesis 2 
Null Hypothesis (H0): The availability of social support does not have a 
significant relationship with the presence of stress/anxiety, emotional lability, and/or 
depression during pregnancy. 
Alternative Hypothesis (H1): The availability of social support has a significant 
relationship with the presence of stress/anxiety, emotional lability, and/or depression 
during pregnancy. 
Research Question 3 
Is there a difference between the birthweight of the offspring of women who 
experience high levels of anxiety or emotional lability during pregnancy and of those 
who do not? 
Hypothesis 3 
Null Hypothesis (H0): There is no difference in newborn birthweight between 
pregnant women who experience high levels of stress/anxiety or high emotional lability 
scores during pregnancy and those who do not. 
Alternative Hypothesis (H1): There is a difference in newborn birthweight 
between pregnant women who experience high levels of stress/anxiety or high emotional 




Theoretical and Conceptual Framework for the Study 
The theoretical basis of this study comes from theories related to mind-body 
interactions, such as functionalism, psychoneuroimmunogy, and allostatic load theories. 
The allostatic and psychoneuroimmunology theories better explain physiological changes 
associated with the development of diseases during pregnancy because they take into 
account neuroendocrine alterations that can affect immune system modulation. During 
pregnancy, there is an important regulation of maternal immune system responses so the 
fetus will not be rejected by the mother (Guleria & Sayegh, 2007). Thus, the activation of 
neuroendocrine pathways that can regulate the immune system may have deleterious 
effects on pregnancy outcomes. 
According to Coussons-Read’s (2005) psychoneuroimmunological theory, 
neuroendocrine changes induced by the stress response during pregnancy can lead to the 
secretion of proinflammatory cytokines and to a reduction of the cytokine IL-10, which is 
essential for immune system regulation during pregnancy (Coussons-Read, Okun, 
Schmitt, & Giese, 2005). This study relates to psychoneuroimmunological theory because 
it proposes that emotional lability, stress, or depression may affect pregnancy’s 
immunorregulation and can lead to the development of pregnancy complications related 
to immune system activation, such as preeclampsia, preterm labor, and abruptio 
placentae. 
The maternal hypothalamic-pituitary-adrenal (HPA) axis undergoes adaptations 
that can help decrease the effects of stress during pregnancy and glucocorticoid exposure 




women who present pregnancy complications may not be able to regulate HPA 
responses, or the induced stress response may override the body’s regulatory capacity. 
According to theory of allostatic load, a lifetime of allostatic load may cause some 
women to be particularly susceptible to the negative consequences of stress and the stress 
response (Hilmert et al., 2008). The theory of allostatic load may be related to pregnancy 
complications because chronic exposure to high levels of cortisol can modulate 
progesterone levels and put pregnancy in danger (Nepomnaschy et al., 2006). 
Nature of the Study  
As the goal of the study was to identify the relationship between emotional factors 
and the development of pregnancy complications, a prospective study was the most 
adequate design. Prospective studies identify correlational relationships as well as risk 
factors for disease development (Creswell, 2009).  Different variables were assessed in 
this study because three different research questions were evaluated.  
Operational Definitions 
Stress: Stress may be understood from both a psychological and physiological 
perspective. Psychological stress is related to cognitive and emotional factors that are 
associated with the appraisal of a threatening event. Physiological stress is the body’s 
potentially damaging reaction to certain events (Monat, Lazarus, & Reevy, 2007).  
Anxiety: Anxiety is defined as a sensation of chronic fear that exists without any 
direct threat. It is commonly correlated with stress and with physiological stress reactions 





Stress/anxiety: As anxiety is highly correlated with stress, for the purpose of this 
study, stress and anxiety will be considered as a single variable. They will also be 
managed as one variable because the Millon Behavioral Medicine Diagnostic Test’s 
Scale AA measures stress and anxiety and provides a single score for both factors 
(Millon, Antoni, Minor, & Grossman, 2006). 
Emotional lability: Patients with emotional lability experience intense endogenous 
moods and periods of apathy and dejection, mixed with anger, anxiety or euphoria. They 
have affect dysregulation and mood instability. Medical patients with emotional lability 
account for approximately 6% of patients with physical illnesses (Millon et al., 2006). 
Depression: Depressive symptomatology includes sadness, incapacity to 
experience pleasure, despair, and incapacity to meet essential requirements of daily life 
such as eating or maintaining personal hygiene (Pinel, 2009).  
Low stress score: A score that ranges from 0 to 50 in the Millon Behavioral 
Medicine Diagnostic Test’s Scale AA (Millon et al., 2006) 
High stress score: A score that ranges from 51 to 100 in the Millon Behavioral 
Medicine Diagnostic Test’s Scale AA (Millon et al., 2006). 
Low emotional lability score: A score that ranges from 0 to 50 in the Millon 
Behavioral Medicine Diagnostic Test’s Scale DD (Millon et al., 2006). 
High emotional lability score: A score that ranges from 51 to 100 in the Millon 
Behavioral Medicine Diagnostic Test’s Scale DD (Millon et al., 2006) 
Preeclampsia: Preeclampsia is a pregnancy disorder that typically starts after the 




pressure of 160mmHg or higher, or diastolic pressure of 110 or higher) and protein in 
urine (2.0 grams or higher in 24 hours) as a result of kidney problems. Preeclamptic 
patients also present an increase in serum creatinin (higher than 1.2mg/dl). Preeclampsia 
affects the placenta, and it can affect the mother's kidneys, liver, and brain (National 
Institutes of Health, 2012).  
Preterm birth: Preterm labor is defined as labor that begins before 37 weeks of 
pregnancy. It is also called premature labor (National Institutes of Health, 2013).  
Abruptio placentae: The premature separation of the placenta, before the baby’s 
birth. It is a cause of vaginal bleeding in the second half of pregnancy and is associated 
with significant perinatal mortality and morbidity (Oyelese & Ananth, 2006). 
Apgar score: The Apgar score is used in the delivery room for the assessment of 
newborn babies. It evaluates respiratory effort, heart rate, muscle tone, reflex irritability, 
and color. For each parameter, a score of 0 to 2 may be assigned, so the total score for 
Apgar may be 10. The Apgar is evaluated at the first minute and 5 minutes after the 
baby’s birth (Lopriore, Burk, Walther, & Beaufort, 2004) 
Birthweight for gestational age: To evaluate if the offspring’s weight is adequate, 
the weight is compared with gestational age, using male and female weight curves 
according to each gestational week (Kramer et al., 2001).  
Low birthweight for gestational age: Birthweight that falls in the 10th percentile or 





Normal birthweight for gestational age: Birthweight that falls in the 50th 
percentile, according to male and female curves of weight for gestational age (Kramer et 
al., 2001) 
High birthweight for gestational age: Birthweight that falls in the 90th percentile 
or higher, according to male and female curves of weight for gestational age (Kramer et 
al., 2001) 
Social support: Defined as the availability of people on whom one can count. 
Social support is about having someone who lets the patients know that they are loved, 
valued, and cared about (Sarason, Levine, Basham, & Sarason, 1983). 
High income: Family income higher than or equal to 85,000 Mexican pesos per 
month, which equals approximately 6,600 USD per month, considering an exchange rate 
of 12.7 (Asociación mexicana de agencias de investigacion de mercado y opinión 
pública, 2012) 
Medium income: Family income that ranges from 11,000 to 84,000 Mexican 
pesos per month, which is an income that ranges from 860 to 6,500 USD per month, 
considering an exchange rate of 12.7 (Asociación mexicana de agencias de investigacion 
de mercado y opinión pública, 2012). 
Low income: Family income that ranges between 0 to 10,000 Mexican pesos per 
month, which is an income that ranges from 0 to 850 USD per month, considering an 
exchange rate of 12.7 (Asociación mexicana de agencias de investigacion de mercado y 




Infections during pregnancy: Any type of infection that the woman might present 
during pregnancy that requires pharmacological therapy was considered in this study. The 
number of registered infections during pregnancy was recorded. The infections that were 
included were upper respiratory tract infections, gastrointestinal infections, genitourinary 
tract infections, and sexually transmitted diseases. Sexually transmitted diseases during 
pregnancy were also evaluated because they have been related to adverse pregnancy 
outcomes (Mullick, Watson-Jones, Beksinska, & Mabey, 2005) 
HPA axis: Hypothalamic-pituitary-adrenal axis. The hypothalamus produces 
hormones called vasopressin and corticotrophin-releasing hormone (CRH). The latter 
stimulates the production of adrenocorticotrophic hormone (ACTH) from the pituitary. 
ACTH acts on the cortex of the adrenal gland and stimulates the production of cortisol 
(Vedhara & Irwin, 2007). 
CRH: Corticotrophin releasing hormone (CRH) is produced by the hypothalamus 
and stimulates the production of adrenocorticotrophic hormone (ACTH) by the pituitary 
(Vedhara et al., 2007). 
ACTH: Adrenocorticotropic hormone (ACTH) is produced by the pituitary gland 
and stimulates the production of corticosteroids by the adrenal gland (Monat et al., 2007). 
Cortisol: Cortisol is produced in the cortex of the adrenal glands and modulates 
many stress-related responses. Cortisol effects include an increase in glucose levels and 
the inhibition of reproductive functions. Cortisol has anti-inflammatory properties 
because it can down-regulate immune processes, such as cytokine production and 




Progesterone: Progesterone is a steroid hormone that belongs to the group of the 
progestins. It is produced by the ovaries and the placenta, and it has a relevant role in the 
maintenance of pregnancy (Pinel, 2009). 
Cytokine: A small protein produced by a cell that can affect the behavior of other 
cells. Cytokines act via specific cytokine receptors and have different functions (Murphy, 
Travers, & Walport, 2008). 
Psychoneuroimmunology: This field involves the study of the interactions among 
the immune system, the nervous system, and behavior. It also considers the relationship 
among the stress response, the neuroendocrine system, and the immune system (Vedhara 
et al., 2007). 
Assumptions   
Although it is clear that the immune system participates in the initiation and the 
pathophysiology of preeclampsia and preterm labor, its participation in the mechanisms 
that lead to placental abruption are not fully known; neither have the participation of 
neuroendocrine responses and the immune system been clearly elucidated in this 
pregnancy complication. The activation of the immune system due to stress-induced 
neuroendocrine changes is a well-known phenomenon, but the specific amounts of stress, 
hormones, or neurotransmitters needed to induce immune system changes that will lead 





Scope and Delimitations  
In this study, I attempted to establish a correlational relationship between 
emotional factors and the development of pregnancy complications; thus, internal validity 
was relevant because possible internal validity threats were the selection of the sample 
and the participation of confounding variables. These might have threatened my ability to 
draw the correct conclusions regarding the correlational relationship between the 
variables. To overcome issues regarding internal validity, a prospective cross-sectional 
design and moderating variables, such as age at current pregnancy, were included in the 
analysis to assess if the development of pregnancy complications could be attributed to 
stress, depression, or emotional lability and not to confounding factors. This project only 
explored psychoneuroimmunological theories during pregnancy regarding the effects of 
emotional factors on preterm labor, preeclampsia, and abruptio placentae. Thus, its 
results may only be applied to these disorders and not to others that may be present 
during the gestational period. As the sample was not  randomly selected and a 
convenience sample was used, this study may have had issues regarding external validity 
because only women who attended a perinatology hospital were evaluated, and these 
women did not represent the absolute population of Mexican pregnant women.  
Progesterone is essential for the adequate regulation of the immune system during 
pregnancy (Guleria et al., 2007). Immune system changes related to the development of 
disease in pregnancy have been associated with high levels of cortisol that decrease the 
production of progesterone (Nepomnaschy, Sheiner, Mastorakos, & Arck, 2007; 




progesterone during pregnancy, the results of this study may not be generalized to 
pathologies not occurring during the gestational period. During chronic stress responses, 
high levels of cortisol are related to suppression of various functions of the immune 
system (Vedhara et al., 2007), which is different from what happens in the pregnant 
woman under stress. In pregnancy, high levels of cortisol lead to decreased progesterone 
levels. On the other hand, there may be possible generalizability of this study’s results to 
other diseases that have been related to emotional factors in which high levels of cortisol 
are present, such as asthma and allergic rhinitis (Elenkov, Iezzoni, Daly, Harris, & 
Chrousos, 2005) 
Limitations 
This study had several limitations. First, no biological factors related to the stress 
responses were be measured, such as cortisol, progesterone, epinephrine, serotonin, and 
interleukin-10. A correlation between stress/anxiety scores, depression scores, and 
emotional lability scores would have been highly appropriate to establish an association 
among emotional factors, neuroendocrine and immune changes, and the development of 
pregnancy complications. Second, this study included pregnant women of all ages 
because I aimed to evaluate the effects of emotional factors in women of a wide range of 
ages. However, there are certain pregnancy disorders, such as preeclampsia, that are more 
prevalent before the age of 20 or after 40 (National institutes of health, 2012). The 
inclusion of women younger than 20 years, or older than 40, may be a confounding factor 




may have had external validity issues because the population that was assessed was not 
random and consisted of women mostly from low- to medium-income families.  
The family income of pregnant women was considered because it may have had 
an influence on the study’s outcomes, as low-income families in Mexico are associated 
with relevant economic difficulties that increase the probability of stressful situations. 
However, the level of social support in Mexican families is very high, and this may 
attenuate the effects of stress generated due to economic factors.  
The Millon Behavioral Medicine Diagnostic, which is the instrument that was 
used to evaluate emotional lability, stress, and depression, had not been used  to evaluate 
pregnant women, nor had it been used in the Mexican population, which may also have 
been a limitation to this study. 
Significance of the Study  
This study contributes to the knowledge regarding how pregnancy disorders may 
be related to emotional factors. Many researchers have already documented the effect of 
stress and anxiety on the development of preterm labor. However, there are research gaps 
regarding the effect of stress on the development of other pregnancy complications, such 
as preeclampsia and abruptio placentae. Furthermore, the participation of other emotional 
aspects such as emotional lability and depression has not been clearly identified in 
pregnancy complications. 
Implications for Social Change 
The practical applicability of this study and its implications for social change 




development of pregnancy disorders related to poor pregnancy and newborn outcomes. 
The presence of a disabled child due to premature birth has important repercussions for 
families and the society in which they live; this is why addressing risk factors for 
pregnancy complications and preterm delivery can promote social change. The benefits 
of this study will not be directly reflected, in the short term, in the mothers who 
participated, or their children. However, the results obtained from the study offer 
information regarding the importance of emotional and social support factors during 
pregnancy that may help promote social change in the future. The information derived 
from this study may allow phsysicans or health psychologists to implement new 
parameters in health care attention for the pregnant woman and establish outlines for the 
prevention of pregnancy complications related to psychosocial factors. By evaluating 
psychosocial factors in the pregnant woman and establishing social support and stress 
management programs, healthcare workers may be able to promote better psychosocial 
environments during the gestational period, and this will lead to better pregnancy 
outcomes and healthy newborns in communities, thus promoting social change. 
Summary 
This study explored the effects of emotional factors such as stress, depression, and 
emotional lability on the development of preeclampsia, abruptio placentae, preterm labor, 
and low birthweight for gestational age in offspring. It also assessed whether social 
support has an effect on stress, depression, or emotional lability scores. 
Several theories in the mind/body field may be related to this study, but this 




allostatic load theory, which propose that emotional factors and stressful responses lead 
to neuroendocrine changes that can alter cytokine profiles and immune system regulation. 
A prospective cross-sectional design was used in order to evaluate if there is a 
causal relationship between the dependent and independent variables. Anxiety/stress, 
depression, and emotional lability scores were obtained by the application of the Millon 
Behavioral Medicine Diagnostic Test. Social support was evaluated by using the short 
version of Sarason’s Social Support Questionnaire. 
The following chapter will address a review of the existing literature regarding 
emotional factors and their relationship with pregnancy complications. The chapter 
begins with the theoretical foundations on which this study was based and it then 
describes the importance of the stress response and how neuroendocrine factors can affect 
the regulation of the immune system during pregnancy. Finally, associations between 
anxiety, depression, emotional lability, and low social support and pregnancy 




Chapter 2: Literature Review 
Introduction 
The literature review focuses on the relationship of emotional factors to maternal 
well being during pregnancy. The review revealed the need for further research regarding 
the biopsychological pathways involved in immune system activation during pregnancy 
and the development of pregnancy complications such as preeclampsia and preterm labor. 
More research is needed in the field of psychoneuroimmunology in pregnant women. 
Researchers have focused on the participation of the immune system in pregnancy 
disorders and, because the immune system may be affected by neurotransmitters derived 
from psychological stress and emotional factors (Elenkov & Chrousos, 2006), it is 
essential to identify psychological risk factors for negative pregnancy outcomes (Lobel et 
al., 2008).  
Maternal psychological environments are very important for pregnancy success 
(Pluess, Bolten, Pirke, & Hellhammer, 2010). Environmental factors are frequently 
ignored by health care professionals, who focus mainly on the biological aspects of 
pregnancy, However, chronic stressors can negatively impact pregnancy outcomes 
(Coussons-Read et al., 2005), and traumatic life events may also lead to health problems 
through the modulation of the inflammatory response (Kendall-Tackett, 2009). 
Preterm delivery is one of the most common pregnancy complications; it occurs 
in 5-10% of pregnancies. It is mainly caused by spontaneous preterm labor, and it is 
considered as a major obstetric complication. Spontaneous preterm labor has been 




Stress and the biological effects of the stress response can influence the 
neuroendocrine, immune, and vascular processes in the maternal and fetal compartments 
that have been implicated in the development of pregnancy complications (Wadhwa, 
Culhane, Rauh, & Barve, 2001). The biologic pathways that participate in stress-induced 
preterm labor, or other stress-related pregnancy complications, are not fully understood 
yet (Kramer et al., 2009).  
Literature Search Strategy  
A search of literature was performed through electronic medical and psychology 
databases. The databases used were Medline, PubMed, HighWire, EBSCO, OVID, and 
PsycINFO. The key words used to conduct the search were stress, pregnancy, immune 
system, preeclampsia, preterm labor, anxiety, depression, emotional lability, HPA axis, 
cortisol, CRH, and abruptio placentae. There was no limit in terms of the years searched, 
and the sources were mainly peer-reviewed journals.  
Theoretical Foundation 
The concept that stress can affect health is not a new one, and it comes from 
various research fields, such as endocrinology, psychology, and neurobiology (Chrousos, 
2009). Several theories relate the development of disease to emotional factors. Among 
them are psychoneuroimmunology theories and allostatic load theory. 
Psychoneuroimmunology theories propose that stress may induce nonspecific 
changes in adrenocortical steroids, hormones, and neurotransmitters, which may provide 
activation or inhibition signals to lymphocytes and, therefore, suppress or enhance 




psychosocial stressors, by modulation of the immune system, may influence certain 
diseases whose onset is influenced by proinflammatory cytokines (Kiecolt-Glaser, 
McGuire, Robles, & Glaser, 2002). Coussons-Read et al. (2005) proposed a theory in 
which they stated that stress, physiology, and immunity are importantly related to the 
pregnant woman’s and baby’s health and that perinatal stress experiences may be harmful 
to pregnancy success. They proposed that the presence of psychosocial stress, associated 
to low social support and low-self efficacy, may induce cytokine production by the 
maternal immune system and therefore lead to pregnancy complications (Coussons-Read 
et al., 2005).  Kendall-Tackett proposed a psychoneuroimmunological theory that links 
psychological trauma with negative health effects based on empirical data obtained from 
patients with childhood trauma, posttraumatic stress disorder, and abuse. He proposed 
that traumatic life events increase levels of proinflammatory cytokines, which can alter 
immune function and increase the risk of health problems such as coronary disease, 
chronic pain syndromes, and so on (Kendall-Tackett, 2009). 
The theory of allostatic load proposes that chronic stress promotes a cumulative 
cost to our neuroendocrine responses that may affect health outcomes (Glei et al., 2007). 
The concept of “allostatic load” was initially introduced to explain the cumulative 
physiological load that results from adaptive responses to challenges, in which wear and 
tear of the systems occur and promote biological dysregulation of the hypothalamic-
pituitary-adrenal (HPA) axis, sympathetic nervous system activation (SNS), and the 




stress, thus, can lead to immune system modulation and alters metabolic and 
cardiovascular processes (Glei et al., 2007). 
The concept that stress can affect health is not a new one, and it comes from 
various research fields, such as endocrinology, behavior, and neurobiology (Chrousos, 
2009) .The evaluation of allostatic load in medical practice can help to predict various 
health outcomes related to cardiovascular disease, physical function, and mortality (Glei 
et al., 2007). Allostatic load in pregnancy may have relevant consequences because of the 
effects that cortisol and catecholamines have on the pregnant woman’s immune system 
and overall physiology. Because of this, during normal pregnancies, the maternal HPA 
axis undergoes adaptations that can help decrease the effects of stress during pregnancy 
and glucocorticoid exposure for the fetus (Brunton et al., 2008; Brunton et al., 2008).  
If the bases of the mind-body problem and its social influences are fully 
understood, researchers may be able to modulate some of the social factors that are 
contributing to the development of disease, making a positive change in this field.  
The Stress Response and Its Association With Disease Development 
Cannon (1957) studied the physiology of emotion and is considered the first 
scientist to do research in this area. He showed that during exposure to stress, the 
sympathetic-adrenal system induces changes in blood pressure and glucose levels. 
Cannon also defined the term homeostasis, which describes how physiological processes 
maintain a steady state in the body (Cannon, 1942; Cannon, 2002). Selye (1950) unified 
many of the observations done by other researchers who tried to explain how living 




pointed out that stress can put life in danger, unless it is followed by an adaptive 
response. According to Selye, stress is an interaction between damage and defense that 
induces changes in the nervous and the endocrine systems that initiate with activation of 
the hypothalamus and the pituitary (Selye, 1950).  
Selye used the term stress and proposed the general adaptation syndrome to 
explain the consequences of stress and the physiological and psychological events that 
occur in response to stress (Chrousos & Gold, 1992). The stress response activates the 
sympathetic nervous system (SNS; (Chrousos, 2009) and the HPA system (McEwen, 
2007).  
Pregnant women may also be susceptible to the effects of the stress response 
(Coussons-Read et al., 2005), and the physiological events that participate in this 
response can lead to pregnancy complications such as preterm delivery (Wadhwa et al., 
2001)  
The Stress Response During Pregnancy  
During pregnancy and lactation, the HPA axis undertakes important adaptations 
that aim to decrease the effects of stress on the mother and her offspring (Brunton et al., 
2008).  Throughout the gestational period, the HPA axis’s adjustments play an important 
role in modulating the effects of the stress response in the pregnant woman and reducing 
fetal exposure to maternal glucocorticoids, which are hormones produced by the adrenal 
gland cortex, and it responds differently depending on the stage of pregnancy. Lower 
cortisol levels at the beginning of pregnancy may promote implantation (Brunton et al., 




2007). During the first trimester of pregnancy the woman is more vulnerable to the 
effects of stress, and the stress response may affect the length of gestation (Hobel & 
Culhane, 2003).  
An HPA hyporesponsiveness to immune challenges has also been reported in the 
third trimester of normal pregnancies, due to a reduced activation of the CRH-secreting 
neurons (Brunton et al., 2005). It is possible that chronic stress during pregnancy may 
lead to cortisol and progesterone changes later in pregnancy, which has been related to 
pregnancy complications. Prospective studies are still needed to provide answers 
regarding the effects of psychological stress during the gestational period (Nepomnaschy 
et al., 2007) and the biological mechanisms that participate in the stress-related override 
of the HPA hyporesponsiveness during pregnancy. 
Stress-Related Immune System Activation During Pregnancy and  
the Development of Disease 
Stress-related interactions between the nervous system and the immune system 
have been related to pregnancy complications due to deregulation of the immune and 
endocrine systems (Coussons-Read et al., 2005). Psychosocial stress has been identified 
as a risk factor for preterm birth and low birth weight for gestational age. These factors 
have been related to altered levels of corticotrophin-releasing hormone, which may have 
relevant immunoregulatory effects that can make the pregnant women more susceptible 
to infections and other complications (Hobel et al., 2003). Studies in mice have shown 




delivery and abortion, because progesterone has important immunomodulating properties 
(Arck, Hansen, Mulac Jericevic, Piccinni, & Szekeres-Bartho, 2007).  
Because many pregnancy complications can be related to an altered regulation of 
the immune system (Guleria et al., 2007) and the immune system can be modulated by 
emotional factors that activate the stress response (Graham, Christian, & Kiecolt-Glaser, 
2006), psychosocial factors such as anxiety, depression, emotional lability, and low social 
support could be associated with the development of some pregnancy complications.  
Stress/Anxiety and Its Relationship to Pregnancy Complications 
Anxiety symptoms such as feelings of worry, apprehension, and nervousness are 
common among pregnant women (Catov, Abatemarco, Markovic, & Roberts, 2010), and 
anxiety disorders are considered risk factors for adverse pregnancy outcomes, which is 
why prompt identification and treatment of these disorders is warranted during pregnancy 
(Littleton, Breitkopf, & Berenson, 2007). Preterm birth is a pregnancy complication that 
is highly related to stress and severe life events. Severe life events present during the 6 
months before pregnancy may pose a higher risk for preterm birth (Khashan et al., 2009). 
Anxiety related to pregnancy has been independently associated with preterm birth as 
well (Catov et al., 2010; Kramer et al., 2009) Moreover, high levels of anxiety are related 
to increased cortisol levels during pregnancy (Dayan et al., 2002) and to the release of 
corticotropin–releasing hormone (CRH) , which have been linked to preterm delivery 
(Mancuso, Schetter, Rini, Roesch, & Hobel, 2004; Wadhwa et al., 2001). Researchers 
have considered CRH a placental clock that participates in pregnancy termination 




50% of women at risk for preterm delivery (Inder et al., 2001). However, not only stress-
related hormones and cytokine changes are increased in the pregnant woman who is 
under stress. Holzman et al. (2009) found an association between high norepinephrine 
and dopamine urine levels and a higher risk for spontaneous preterm labor. This indicates 
that activation of the sympathetic nervous system participates in stress-induced 
pregnancy complications as well (Holzman et al., 2009). 
Although most researchers have reported an association between psychosocial 
factors and pregnancy complications, others have not found such relationship. Littleton et 
al. (2006) performed a meta-analysis to evaluate the correlations between anxiety 
symptoms and adverse perinatal outcomes and did not find any associations (Littleton et 
al., 2007).  
Depression and Its Relationship to Pregnancy Outcomes 
Depression is another stress-related mental health concern that impacts many 
pregnant women. The age range in which the onset of depressive symptoms occurs in 
women is between 20 to 40 years, which is the age range when most women may become 
pregnant. As the incidence of major depressive disorder in pregnant women has been 
reported to be as high as 16%, it is important that healthcare workers become aware of 
the frequency of depressive symptoms in pregnant women and the health consequences 
that undetected or untreated depression can have on pregnancy outcomes (Marcus & 
Heringhausen, 2009). The presence of depression during the implantation period is not 
related to pregnancy cancellation and does not affect in vitro fertilization success rates 




outcomes later in pregnancy because it is associated with higher levels of cortisol and a 
decrease in HPA axis negative feedback (Von Werne Baes, de Carvalho Tofoli, Martins, 
& Juruena, 2012). Increases in cortisol levels during pregnancy have been associated with 
the release of placental CRH, a hormone that is a key player in the initiation of labor 
(Dayan et al., 2006). Pregnant women with depression have a higher risk of developing 
preterm labor, delivering a low birthweight for gestational age baby (Grote et al., 2010), 
or delivering a baby with a low Apgar score (Goedhart et al., 2010; Grote et al., 2010). 
Also, obesity and stressful events may increase the effect of depression on preterm labor 
(Li, Liu, & Odouli, 2009). Furthermore, after delivery, the prevalence of 
proinflammatory cytokines and high cortisol levels have been associated with postpartum 
depression (Corwin & Pajer, 2008). This is why high cortisol levels and high 
psychological reactivity to stress during pregnancy may help identify those women who 
are likely to develop postpartum major depression (Nierop, Bratsikas, Zimmermann, & 
Ehlert, 2006). 
Depression can also be considered a risk factor for preeclampsia (Bansil et al., 
2010) because moderate to severe depression has been related to a three-fold increased 
risk for developing preeclampsia (Qiu, Sanchez, Lam, Garcia, & Williams, 2007) 
Emotional Lability and Pregnancy Outcomes 
Pregnant women also experience other psychosocial stressors that can exert a 
physiological impact. Approximately one-half of pregnant women tend to report 
insomnia, and others may present mood lability, anxiety, or depression during the third 




to Tam and Chung (2007), emotional lability can be present during the postpartum blues, 
presenting as mood irritability, anxiety, headaches, and sleep disturbances, but it should 
also be differentiated from depression if the symptoms persist (Tam & Chung, 2007). 
Emotional lability should be identified in pregnant women because pregnant women tend 
to report mood lability throughout the gestational period (Clark, Skouteris, Wertheim, 
Paxton, & Milgrom, 2009). According to McDonald (1968), women with labor 
difficulties tend to be more sensitive and apprehensive; those women who develop 
preterm labor tend to have more negative attitudes toward pregnancy and emotional 
immaturity; and women with preeclampsia tend to be unhappy and under stress 
(McDonald, 1968). Patients with affective disorders and schizophrenia should also be 
monitored during the gestational period because they have a higher risk of fetal and 
neonatal complications as well (Jablensky, Morgan, Zubrick, Bower, & Yellachich, 
2005).  
Maternal Emotional Factors Associated With Changes in the Offspring 
Stress and anxiety during pregnancy not only affect pregnancy outcomes; animal 
models have shown that stress during pregnancy has programming effects on the 
development of the offspring and, in humans, it is related to increased infant illnesses 
during the first year of life (Beijers, Jansen, Riksen-Walraven, & de Weerth, 2010). For 
example, children exposed prenatally to stress have a 25% increased risk of being 
hospitalized due to a severe infectious disease and a 30% increased risk of presenting a 




While stress during the first trimester has a relevant effect on the length of 
pregnancy (Hobel et al., 2003), chronic maternal stress during the third trimester and the 
postpartum period increases maternal basal salivary cortisol and affects stress-related 
behavior and growth in the male offspring and HPA axis functioning in female and male 
offsprings (Emack, Kostaki, Walker, & Matthews, 2008). Male offsprings of prenatally 
stressed-rats display increased anxiety behavior, and female and male offsprings of 
stresses rats also display an increased production of CRH that may be related to altered 
glucocorticoid negative feedback mechanisms in the limbic system (Brunton & Russell, 
2010). 
The fetal exposure to the neuroendocrine changes during maternal stress can also 
result in intrauterine programming that leads to early onset of certain adult disorders like 
an increased risk of coronary artery disease, diabetes, and stroke (Hobel et al., 2003). 
Furthermore, maternal psychological stress during pregnancy has been related to immune 
system changes in the offspring and promotes a higher incidence of allergic processes in 
the offspring such as asthma, eczema, urticaria, and so on. (Entringer et al., 2008).  
As previously mentioned, emotional factors may play a role in the development of 
pregnancy complications and on newborn outcomes. This is why the identification of 
possible stress mediating or buffering factors is relevant. According to Häusser (2012), 
social support and social identity may have a stress-buffering effect (Häusser, 
Kattenstroth, van Dick, & Mojzisch, 2012) and may decrease the incidence and 




support is also relevant in pregnant women, on whom social support may decrease the 
effects of stressful situations on pregnancy outcomes (Dunkel Schetter, 2010) 
The Importance of Social Support During Pregnancy  
Social support has been defined as the availability of people on whom a certain 
individual can rely on, and the existence of people that let the patient know that they are 
valued and cared about  (Kim, Sherman, & Taylor, 2008; Vangelisti, 2009). The 
relationship between stressful events and the development of disease is stronger among 
subjects who report lower levels of social support compared to those with high levels of 
support. This may be due to the fact that social support acts as a moderator of the stress 
response (Sarason & Sarason, 2009) 
The presence of maternal stress can increase the incidence of preterm birth. 
However, not all women who experience stress during pregnancy deliver preterm. This is 
why vulnerability to stress should also be considered, and the behavioral mechanisms that 
mediate the effects of stress during pregnancy should be evaluated (Hobel & Culhane, 
2003).   
Pregnancy, by itself, is associated with anxiety and stress because of 
psychological adjustments that have to take place due to life changes of the pregnant 
woman and the lack of emotional adjustment may increase the risk of pregnancy and 
neonatal complications. However, one of the most important risk factors for negative 
pregnancy outcomes is the absence of social support, because it affects maternal 
emotional well-being (Elsenbruch et al., 2007). Less social support is also correlated with 




Smith, Belanger, & Yonkers, 2009) and to increased anxiety symptoms as well (Littleton 
et al., 2007). According to Rodriguez et al. (1999), the adjustment to pregnancy and the 
presence of relevant medical symptoms during pregnancy can be affected by the amount 
of perceived stress and social support (Rodriguez, Bohlin, & Lindmark, 1999). 
 On the other hand, prenatal social support has been positively correlated with 
infant birth weight through adequate fetal growth. Therefore, interventions should 
promote support within the pregnant woman’s social network, and psychosocial risk 
factors that may lead to adverse pregnancy and neonatal outcomes should be identified 
(Feldman, Dunkel-Schetter, Sandman, & Wadhwa, 2000).  
Relationship of This Study to Previous Research  
Most researchers who have focused on evaluating the effects of stress on 
pregnancy complications have developed cohorts and prospective cross-sectional studies 
in which pregnant women were assessed at the beginning of pregnancy and followed 
until delivery (Coussons-Read et al., 2005; Nepomnaschy et al., 2006). Others evaluated 
emotional factors in pregnant women during the second and the third trimesters (Nierop 
et al., 2006; Rahman, Bunn, Lovel, & Creed, 2007).  
This study employed similar statistical methods to those used in other studies that 
have evaluated the effects of emotional factors on the development of different pregnancy 
complications. Dayan et al. (2002) conducted a cohort study to evaluate the role of 
anxiety and depression on the development of preterm labor and they performed a 
logistic regression analysis to search for associations (Dayan et al., 2002). Other 




anxiety or depression on spontaneous preterm birth (Holzman et al., 2009; Kramer et al., 
2009; Nasreen, Kabir, Forsell, & Edhborg, 2010). Analysis of variance (ANOVA) is 
useful in evaluating the role of psychosocial factors in pregnancy as well. Elsenbruch et 
al. (2007) compared three groups of social support with regard to pregnancy outcomes by 
using ANOVA (Elsenbruch et al., 2007). In this study, factorial ANOVA and 
multivariate analysis of covariance (MANCOVA) were performed in the analysis of the 
role of psychosocial variables on the development pregnancy complications. 
Summary and Conclusions 
 Pregnancy has been related to anxiety by itself because of the uncertainty that 
comes with the prospect of having a new baby. It is also a vulnerable state for women 
because of the multiple physiological changes that take place so the baby can grow in the 
mother’s womb.  The immune system is highly regulated during pregnancy and it is this 
regulation that permits the mother to tolerate the semiallogenic fetus (Guleria et al., 
2007). Due to this delicate regulation and to the intricate connections between the 
immune and the nervous systems, psychoneuroimmunological theories have proposed 
that emotional factors may be able to affect immune system homeostasis during 
pregnancy and lead to pregnancy disorders (Coussons-Read, Okun, & Simms, 2003).  
The HPA axis also undergoes changes during pregnancy. In normal pregnancies, women 
usually present an HPA axis hyporesponsiveness promoted by the progesterone 
metabolite, allopregnanolone (Brunton et al., 2008). This HPA regulation favors the 
continuing of pregnancy. For example, implantation is related to lower cortisol levels; 




exposure in the offspring (Kapoor, Dunn, Kostaki, Andrews, & Matthews, 2006) 
However, it is believed that severe stressful events or chronic stress during pregnancy 
may annul pregnancy’s HPA axis regulatory mechanisms and lead to pregnancy 
complications through the activation of the immune system (Coussons-Read et al., 2005). 
Furthermore, high fetal exposure to maternal cortisol has been related to neuroendocrine 
changes in the newborn (Emack et al., 2008). 
 Low social support has also been linked to pregnancy complications and this may 
due to increased stress levels in these women (Zachariah, 2009). There are still research 
gaps regarding the mechanisms that lead to changes in HPA axis hyporesponsiveness 
(Douglas, Brunton, Bosch, Russell, & Neumann, 2003), the pathways that mediate an 
immune system shift towards Th1 responses, and to increased vulnerability to the effects 
of emotional factors during pregnancy. 
 The following chapter explains the nature of this study, in which the participation 





Chapter 3: Research Method 
Introduction  
This chapter includes a description of the study design, where it took place, and 
the type of population that was evaluated. It includes a rationale for why this particular 
design was selected to answer the research questions. The sample characteristics, the 
power analysis that was performed, and the required sample size will also be presented. 
In this chapter, the instrumentation, the data collection process, the analysis, and the 
ethical considerations will be described as well. 
The objective of this study was to evaluate the effect of stress, anxiety, and 
depression during pregnancy on the development of preeclampsia, abruptio placentae, 
and preterm delivery, as well as on newborn birthweight. The relationship was controlled 
for the effect of age, number of previous pregnancies, and socio-economic status 
(Creswell, 2009). I also evaluated whether perceived social support may have an effect 
on stress/anxiety, depression, and emotional lability scores during pregnancy.  
Research Design and Rationale 
A prospective, cross-sectional, quasiexperimental design was performed in which 
individuals were not randomly assigned because a convenience sample was studied 
(Creswell, 2009). Prospective studies are appropriate for evaluating whether certain 
conditions may participate as risk factors for specific outcomes. A cross-sectional 
approach was used because variables were looked at during a particular point in time. 
The sample included only women who were attended at the National Institute of 




Researchers who have evaluated the effects of emotional factors on pregnancy 
complications have also performed prospective cross-sectional studies (Feldman et al., 
2000; Kramer et al., 2009) or used similar approaches (Khashan et al., 2009). 
Three research questions were explored that included different variables. For the 
first research question, logistic regression analyses were performed in which the 
dependent categorical variables were preeclampsia, preterm labor, abruptio placentae, 
and low birthweight for gestational age. The independent, numerical variables were 
stress, depression, emotional lability, and social support scores. The moderating or 
intervening variable was the Social Support Questionnaire score. The control variables 
were age at pregnancy and number of previous pregnancies. For the second research 
question, a multivariate analysis of covariance (MANCOVA) was performed in which 
stress/anxiety scores, emotional lability, and depression were the quantitative dependent 
variables, and the Social Support Questionnaire score was coded as a categorical 
independent variable that was coded as high, medium, or low. The covariates were 
mother’s age at pregnancy and the number of previous pregnancies. For the third research 
question, a factorial ANOVA was performed in which the dependent quantitative variable 
was newborn birthweight and the mother’s stress/anxiety scores (coded as high or low) 
and emotional liability scores (coded as high or low) were the independent categorical 
variables. More information about data analysis and hypotheses will be covered later in 
this chapter. 
In this prospective study, data were collected at different points. The first data 




of the Millon Behavioral Medicine Diagnostic Test and the Social Support Questionnaire, 
as well as the gathering of demographic information. The trimester in which the 
participant was evaluated was registered for control purposes. The second data collection 
took place at delivery or pregnancy termination. The information that was collected at 
this last point included the socioeconomic status of the mother, type of delivery, time of 
delivery (number of gestational weeks), development of pregnancy complications, 
newborn Apgar score, and birthweight. Delivery and newborn information was obtained 
from medical records, with required authorization. 
Setting and Population  
The setting of the study was the National Institute of Perinatology located in 
Mexico City, Mexico, which is a government-owned research hospital. This hospital 
attends a high volume of patients per day who require perinatal healthcare. The 
participants were pregnant women ranging from 18 to 40 years old who were attended at 
this hospital. Women who were included in this study were those who were in the first 
trimester, second trimester, and third trimester of pregnancy. 
Sample and Sampling Procedure 
Due to difficulties in transportation in Mexico City and to the large sample 
required for the realization of this study, all participants were recruited from a 
perinatology hospital that provides health care to a large number of patients per day. A 
convenience sample was used for this study because all patients were recruited 




Inclusion, Noninclusion, and Exclusion Criteria 
In order to meet the study’s inclusion criteria, participants needed to be pregnant 
women in the first, second, or third trimester of pregnancy and between the ages of 18 
and 40 years. Women of all socioeconomic statuses were included in this study. The 
noninclusion criteria, which were the criteria by which pregnant women were not asked 
to participate in the study, were as follows: being pregnant with a history of gestational 
hypertension in previous pregnancies. Exclusion criteria, which were the criteria by 
which participants would have their study participation suspended, were as follows: (a) 
voluntarily requesting to leave the study, (b) not continuing pregnancy assessment at the 
National Perinatology Institute and not being reachable to evaluate pregnancy outcome, 
and (c) having pregnancy loss before the 20th week of gestation. Criterion-based sampling 
was used because participants were selected from a group of pregnant women attended at 
a public hospital. All women were evaluated at the National Perinatology Institute in 
Mexico City. 
Power Analysis and Sample Size  
A search for effect sizes between stress, anxiety or depression, and pregnancy 
complications and effect sizes between stress and newborn outcomes was performed 
using medical and psychological databases. The effect size for anxiety and medical 
disorders during pregnancy is d = 0.808, and the effect size for depression and medical 
disorders during pregnancy is d = 0.725 (King et al., 2010). The effect size for stress and 
preterm labor is d = 0.840 and r = 0.387, respectively (Lobel et al., 2008).  The effect size 




Tilden, 1983). The effect size for low social support and pregnancy complications is R2 = 
0.082, r = 0.286 (Elsenbruch et al., 2007). The effect size for stress and low birthweight 
is R2 = 0.67, r = 0.818 (Rondo et al., 2003). The correlation between negative life events, 
low social support, and illness development is r = 0.48 (Sarason, Sarason, Potter, & 
Antoni, 1985). 
A power analysis was performed considering an accepted value for power at 0.80 
and an alpha level at 0.05. Considering that depression and anxiety have a prevalence 
during pregnancy of approximately 18% (Karmaliani et al., 2009) and an effect size of  r 
= 0.382 for pregnancy complications, a total of 265-275 women were required to be in 
the study. 
Procedures for Recruitment, Participation, and Data Collection 
Recruitment Procedures 
Women were asked to participate while they were in the waiting room for any 
pregnancy appointment. I was the only person administering the tests and questionnaires 
to the participants. Information regarding the objectives of the study and participation in 
it was provided. If women agreed to participate, they read and signed an informed 
consent letter (Appendix A), acknowledging that they had received appropriate 
information and were eager to freely participate in the study. The approximate total time 
that participants took to finish the MBMD test and the SSQ was 35 minutes. If they were 
interrupted by being called for an appointment, they finished after consultation. Women 
were given a telephone number where they could reach me in case they did not deliver at 




participants so that I could contact them if they delivered elsewhere. Women were 
informed that the second phase of data collection would be done by obtaining 
information from their medical records. They were informed that they could contact me 
at any time throughout the study, and that if they wished to know their scores from the 
MBMD Test or the Social Support Questionnaire, I could contact them after delivery. All 
participants received the telephone number and the e-mail address with which they could 
contact me. 
Demographics 
The demographic data collected at study enrollment during the first trimester of 
pregnancy included age at current pregnancy, number of previous pregnancies, and the 
gestational week at which the evaluation was taking place. 
Data Collection 
The data collection tools that were used in this study were a short demographics 
questionnaire, the Millon Behavioral Medicine Diagnostic Test, and the short version of 
the Social Support Questionnaire. Medical records were essential for the second phase of 
the data collection process, in which pregnancy outcomes were recorded. 
Because this is was a prospective cross-sectional study, data were collected at two 
points. The first data collection effort was performed during the first, second, or third 
trimester of pregnancy. Data that were obtained at this point were demographic 
information such as age at current pregnancy, the number of the current pregnancy, 
gestational week at which the evaluation took place, social status, and economic status. 




scores, and emotional lability scores.  With the SSQR, perceived social support scores 
were acquired. Because the hospital where the study took place has a high volume of 
patients, the approximate calculated time for the first data collection effort was 4 months. 
Two hundred and seventy-five patients were supposed to be included. After the initial 
data acquisition, the numerical and categorical variables were entered into an SPSS 
database, and women were followed until pregnancy termination. After delivery, the 
development of preeclampsia, preterm labor, or abruptio placentae was confirmed in the 
medical record of the mother. The gestational week in which delivery occurred and the 
presence of maternal infections during pregnancy were obtained as well.  Apgar scores 
and birthweight were collected from the newborn’s medical record.  
The tests were completed in paper format. All the written tests and demographic 
questionnaires were kept in a locked filing cabinet. The written tests and questionnaires 
were kept in a locked filing cabinet at my home, and the SPSS file with all the results was 
saved in my laptop computer’s hard disk and Time Capsule. 
During the first data collection process, the MBMD test, the SSQ, and the 
demographic questionnaire were kept in a privacy envelope for each participant. The 
MBMD test only showed the assigned study number for each participant and her 
birthdate. The envelope showed the participant’s birth date and the assigned participant 
number as well.  However, this information was not easy to associate with the participant. 
For example, if the participant’s birth date was June 5, 1965 and her assigned number 
was 57, the number that appeared on her envelope was 57-050665. Every envelope was 




took out the MBMD test from each participant and scored the test by using Pearson’s Q 
local software. I entered the test’s answers manually. Pearson’s Q local software required 
that the test’s answers be entered twice in order to eliminate typing errors. The MBMD 
test scores were only linked to the participant by the number formed by the assigned 
number and the participant’s birthdate. Nobody at Pearson Assessments was able to 
identify the participants because they only had their assigned study numbers and 
birthdates. The results obtained from Pearson Assessments were saved in a .pdf file for 
each participant; the files were saved in my computer, and each file had the participant’s 
birthdate and the study number that was assigned to each participant. All files were 
password protected. The test results were uploaded into an SPSS password-protected file. 
The SPSS files that contained the databases with the test results were locked and saved in 
my computer’s hard disk and Time Capsule. I kept the information regarding the 
participant’s name, medical record number, birthdate, phone number or email, and 
assigned study number in a password-protected file in my computer. 
The second data collection process involved the use of medical records. I filled in 
the required information on a sheet of paper that had the participant’s assigned study 
number; the information was then uploaded to the SPSS database. This sheet of paper 
was kept in the participant’s envelope and locked in a filing cabinet as well.  
Instrumentation  
Millon Behavioral Medicine Diagnostic 
The MBMD is based on the Millon Behavioral Health Inventory (MBHI), which 




in the United States by Pearson Assessments, and I have been authorized by this 
company as a test administrator. The estimated administration time is 20-25 minutes. 
The MBMD is composed of 165 items and 29 clinical scales, and it is useful in 
the evaluation of psychological factors that may influence the clinical course or the 
treatment of medically ill adult patients. The phenomena evaluated by the MBMD are 
response patterns (disclosure, desirability, and debasement), negative health habits 
(alcohol, drugs, eating, caffeine, inactivity, and smoking), psychiatric indications 
(anxiety-tension, depression, cognitive dysfunction, emotional liability, and 
guardedness), coping styles (introversive, inhibited, dejected, cooperative, sociable, 
confident, nonconforming, forceful, respectful, oppositional, and denigrating), stress 
moderators (spiritual absence, illness apprehension, functional deficits, pain sensitivity, 
social isolation, and future pessimism), treatment prognostics (interventional fragility, 
medication abuse, information discomfort, utilization excess, and problematic 
compliance), and management guides (adjustment difficulties and psychiatric/ 
psychosocial referral (Millon et al., 2006). 
The reliability of the MBMD test, estimated by internal consistency and test-retest 
analyses, showed an internal consistency of rtt,=.79 and a median test-retest coefficient 
of rtt = .83. Regarding the validity of the MBMD test, the MBMD scales were correlated 
with other measures such as BDI and the BSI depression scales (Millon, 2012).  The test-
retest reliability was estimated with a sample of N = 41, and the results obtained were as 
follows: psychiatric indications (rtt = .79 to .88); coping style (rtt = .71 to .90); stress 




guide (rtt = .78 to .81). The median for all scales is rtt = .83 (Millon, 2012). Reviewers of 
the MBMD scales have reported variable to good internal consistency and indicated that 
the scales addressing psychosocial features showed alpha coefficients close to or superior 
to 0.8 (Strack, 2008).  
The scales included in the MBMD were validated by an item-sorting procedure in 
which various medical professionals placed the items into scales for which they were 
initially written. The items that were sorted correctly by most of the medical 
professionals were maintained on the test. Afterward, the items were correlated with 
many other measures that evaluated similar phenomena to each of the scales. For 
example, the MBMD depression scale was correlated with the BDI (.87) and with the BSI 
depression scale (.58) (Millon, 2012). 
The convergent correlations between MBMD scales and other measurement 
divides with well established validity were moderate to high, with the exception of two 
aspects: problematic compliance and utilization excess. The test authors refer that these 
may be due to complex and variable patient behavior (Millon et al., 2006). 
The various scales of the MBMD may be relevant to different clinicians. For 
example, psychometricians are interested in the results of all scales, but clinicians 
(physicians, surgeons, etc.) are mostly interested in psychiatric indicators and stress 
moderators because these refer to patient characteristics that are directly influencing 
clinical decisions (Strack, 2008). The Spanish Q local MBMD answer sheets will be used 
to administer the test, and the scores for the MBMD test will be obtained by using 




Social Support Questionnaire 
The Social Support Questionnaire (SSQ) evaluates two aspects of social support: 
the amount of perceived social support and the degree to which this social support is 
satisfying. The SSQ has an alpha coefficient of internal reliability of 0.97, which is a high 
reliability; criterion validity tests demonstrated a negative correlation between the SSQ 
and a depression scale (Sarason et al., 1983). For this study, the short form of the Sarason 
Social Support Questionnaire will be used, which is also known as the SSQSR. The short 
form of the SSQ has high internal reliability and a high correlation with the SSQ. It 
consists of 12 items that have scores that range from 1 (very dissatisfied) to 6 (very 
satisfied). The SSQSR odd-numbered items assess the participants’ social support 
network, and the even-numbered items assess the extent to which they are satisfied with 
the level of support received.  Satisfaction items are rated on 6-point scales in which 1 = 
very dissatisfied and 6 = very satisfied. The maximum score for the social support 
network items is 54, and the maximum score for the items that evaluate satisfaction with 
social support is 36. The scores that reflect the number of individuals in the patient’s 
network as well as the satisfaction with support are obtained by summing across items. 
The total social support score will be calculated by adding the score from the social 
support network and the score from the satisfaction with social support items. The 
maximum score will be 90. This questionnaire takes less than 5 minutes to administer 
(Sarason, Sarason, Shearin, & Pierce, 1987), and it will be hand scored by a research 





The data that was  collected from mothers’ and newborns’ medical records during 
the first week after delivery was the number of infections during the first, second, and 
third trimesters; the development of pregnancy complications such as preeclampsia, 
abruptio placentae, and preterm labor; the gestational week in which delivery occurred; 
neonatal Apgar scores; and the newborn’s birthweight. The newborn’s weight was also 
considered as low, adequate, or high for gestational age by using weight-for gestational-
age curves. The socioeconomical status was also obtained from the social worker’s 
evaluation in the medical record. 
Measures of Social Support and Emotional Factors 
Social Support Network Scores 
These scores were obtained using the short version of the Sarason’s Social 
Support Questionnaire that consists of 12 items. The six odd number items assess the 
participants’ social support network.   The maximum score for the social support network 
items is 54 (Sarason et al., 1987). 
Satisfaction With Social Support Scores   
These scores were obtained using the short version of the Sarason’s Social 
Support Questionnaire  (SSQ) that consists of 12 items. The six even-numbered items 
assess the extent to which they are satisfied with the level of support received. 
Satisfaction items are rated on 6-point scales where 1 = very dissatisfied and 6 = very 
satisfied. The maximum score for the items that evaluate satisfaction with social support 




Overall Social Support Score 
The total social support score was calculated by adding the score from the social 
support network items and the score from the satisfaction with social support items. The 
maximum score was 90. 
High social support score. High social support was defined as having an overall 
social support score that ranged from 68-90 in the SSQ. 
Medium-high social support score. Medium social support was defined as 
having an overall social support score between 46-67 in the SSQ. 
Medium-low social support score.Medium social support was defined as having 
an overall social support score between 23-45 in the SSQ. 
Low social support score. Medium social support was defined as having an 
overall social support score between 0-22 in the SSQ. 
Stress/Anxiety Scores 
These scores were calculated by using the MBMD Test’s Anxiety-Tension Scale 
AA. The maximum score was 100. It is believed that high scores on this scale may suffer 
from numerous somatic disorders (Millon et al., 2006). 
Low stress score. Low stress score was defined as having a stress/anxiety score 
between 0-50 in the MBMD. 
High stress score. High stress score was defined as having a stress/anxiety score 





These scores were calculated by using the MBMD Test’s Depression Scale BB. 
The maximum score was 100.  High scores on this scale are likely to intensify the 
discomfort of their psychological and physical problems (Millon et al., 2006). 
Emotional Lability Scores 
These scores were calculated by using the MBMD Test’s Emotional Lability 
Scale DD. The maximum score was 100. High scorers on this scale tend to experience 
endogenous mood changes, apathy and dejection (Millon et al., 2006). 
Low emotional lability score. Low emotional lability was defined as having a 
stress/anxiety score between 0-50 in the MDMB. 
High emotional lability score. High emotional lability was defined as having a 
stress/anxiety score between 51-100 in the MBMD. 
Nature of the Scale for Each Variable  
Age at current pregnancy. This variable was considered as a numerical variable. 
Number of previous pregnancies. This variable was considered as a numerical 
continuous variable 
Gestational week at which the evaluation is taking place. This variable was 
considered as a numerical variable. 
Current social status. This variable was considered as a nominal categorical 
variable and it will be coded as married, single, divorced, widowed. 
Economical status. This variable was considered as a ordinal variable and it was  




Number of maternal infections during pregnancy. This variable was considered as 
a numerical interval value. 
Development of preeclampsia. This variable was considered as nominal 
categorical variables and was coded as yes/no. 
Development of abruptio placentae. This variable was considered as nominal 
categorical variables and was coded as yes/no.  
Development of preterm labor. This variable was considered as nominal 
categorical variables and was coded as yes/no. 
Depression score. This variable was considered as a numerical interval variable. 
Anxiety/stress score. This variable was considered as a numerical interval 
variable. 
Emotional lability score. This variable was considered as a numerical interval 
variable.  
Social support score. This variable was considered as an interval variable for 
logistic regression and as ordinal (coded as low, medium, high) for the multivariate 
analysis of covariance. 
Newborn’s weight. This variable was recorded as numerical interval variable.  
Newborn’s weight for gestational age. It was considered as an ordinal variable 
depending on its relationship with gestational age. It was coded as low, normal or high 
for gestational age. 
Newborn’s Apgar scores at the first minute and after five minutes. This variable 




Data Analysis Plan 
 The IBM SPSS Statistics 20.0 Premium software was used for data analysis.  
A data file was created which will contain the variable names, their type, and their 
values (George & Paul, 2010). A study number was assigned to each participant. The 
study number will consist in the participant’s birthdate and an assigned study 
number. For example if the participants birth date was June 5th, 1965 and her 
assigned number was 57, the number that was assigned to her was 57-050665. All 
the participant’s data was assigned to this number and this  ensured confidentiality of 
the information because only the researcher was able to associate the data with each 
participant. The first data was entered to the data file as soon as the first data 
collection phase ends. The rest of the data was entered for each participant after 
pregnancy termination. 
 Before performing the analysis, data cleaning procedures were performed. 
The preanalysis data screening  assured the accuracy of the data and  consisted on 
examination of the data by performing descriptive statistics and frequency 
distribution. I verified that all cases had values within possible range and that all 
cases had values that corresponded to the coded values for each variable.  
 A research assistant from the National Institute of Perinatology controlled the 
quality of the data that was analyzed. Additionally, a search for missing data was 
done. The missing data was handled by replacing missing data with the mean values.  
The preanalysis data cleaning also included the assessment of outliers (extreme 




that were performed in this study. Outliers were identified using Mahalanobis 
distance and the researcher decided which outliers should be dropped from further 
analysis (Mertler & Vannatta, 2010). 
 Finally, data was tested for normality, linearity, and homoscedasticity 
because these are three assumptions for multivariate statistical analyses. Univariate 
normality was tested by using the normal probability plot (normal Q-Q plot), 
skewness and kurtosis, and the Kolmogorov-Smirnov statistic. If data were 
substantially deviated from normal, I  evaluated if data transformations using a 
square root transformation or a log transformation were required. After 
transformation of the data, normality was reevaluated. Linearity is important in 
multivariate analyses because many techniques are based on linear relations. 
Linearity was be evaluated with residual plots. Homoscedasticity was evaluated by 
using the Levene’s test to assess the homogeneity of variances (Mertler et al., 2010). 
Before performing the analyses for the three research questions, an analysis of the 
demographical variables was performed, which  consisted in frequency distribution and 
central tendency measures (mean, mode, median).   
Research Questions 
Research Question 1 
Is there a significant relationship between the presence of stress/anxiety, 
depression and/or emotional lability with the development of preeclampsia, abruptio 





Null hypothesis (H0). There is no significant relationship between stress/anxiety, 
depression, emotional lability, and the development of preeclampsia, abruptio placentae, 
preterm labor and low birthweight for gestational age. 
Alternative hypothesis (H1). There is a significant relationship between 
stress/anxiety, emotional lability and depression and the development of preeclampsia, 
abruptio placentae, preterm labor, and low birthweight for gestational age. 
Logistic regression analyses were performed to evaluate the degree in which 
preeclampsia, abruptio placentae, preterm birth and low birth weight-for gestational age 
(coded as present or not present) were predicted by anxiety/stress, emotional liability and 
depression (independent quantitative variables). Logistic regression aims to classify 
participants into groups. It may be considered as an extension of multiple regression, but 
in logistic regression the dependent variable is categorical (Mertler et al., 2010).                                     
Four sets of logistic regressions were performed, one  for preeclampsia, one for abruptio 
placentae, one for preterm labor, and one for low birth weight for gestational age, as 
dependent variables. The independent variables were stress/anxiety scores, emotional 
lability scores and depression scores. Moderating or intervening variables for regression 
analysis were the total social support score. The control variables were  age at pregnancy, 
family income, and social status. 
Considering that depression and anxiety have a prevalence during pregnancy of 
approximately 18% (Karmaliani et al., 2009), and an effect size of r=0.382 for pregnancy 
complications, for the regression analysis, a total of  265-275 women should have been 




The main output components that  helped  interpret the results from logistic 
regression were goodness of fit indices, the-2 log likelihood, Cox &Snell R Square and 
Nagelkerke R square. R2 indicates the proportion of variability in the dependent variable 
that may be accounted for by predictor variables. The last component of the output was 
the Wald statistic, in which R was the partial correlation coefficient between the 
independent variables and the dependent variable (Mertler et al., 2010). 
Research Question 2 
Does the availability or unavailability of social support during pregnancy have a 
relationship with the presence of stress/anxiety, emotional lability and or depression?       
Null hypothesis (H0). The availability of social support does not have a 
significant relationship with the presence of stress/anxiety, emotional lability and/or 
depression during pregnancy. 
Alternative hypothesis (H1). The availability of social support has a significant 
relationship with the presence of stress/anxiety, emotional lability and/or depression 
during pregnancy. 
A multivariate analysis of covariance  (MANCOVA) was performed to evaluate 
the relationship between stress/anxiety scores, emotional lability and depression, as 
quantitative dependent variables; and the social support score (coded as high, medium-
high, medium-low, low) as a categorical independent variable. The covariates were 
mother’s age at pregnancy and the number of previous pregnancies. 
MANCOVA searches for statistically significant mean differences between 




is useful when researchers want to control de effects of concomitant variables (Mertler et 
al., 2010). 
MANCOVA’s results initially showed homogeneity of variance-covariance with 
Box’ test. If the Box’s test was significant, then Pillai’s Trace was used for  multivariate 
test statistic. However, if equal variances were assumed with Box’s test, then a Wilk’s 
Lambda statistics was used when interpreting the homogeneity of regression slopes. The 
results of homogeneity of regression slopes were examined using the F ratio and the p 
value and effect size for each factor’s main effect (Mertler et al., 2010). 
Research Question 3 
Is there a difference between the birthweight of the offsprings of women who 
experience high levels of anxiety, depression or emotional lability during pregnancy, and 
those who do not? 
Null hypothesis (H0). There is no difference in newborn birthweight between 
pregnant women who experience high levels of stress/anxiety, depression or high 
emotional lability scores during pregnancy, compared to those who do not. 
Alternative hypothesis (H1). There is a difference in newborn birthweight 
between pregnant women who experience high levels of stress/anxiety, depression or 
high emotional lability scores during pregnancy, compared to those who do not. 
A factorial design experiment was done because two independent variables were  
analyzed regarding their independent or simultaneous effects on the dependent variables 




When research designs include more than one factor, they are called factorial 
designs. Factorial analysis of variance (ANOVA) tests the mean differences with respect 
to some dependent variables. It also allows the researcher to test group differences and to 
test for interaction effects between various levels of the independent variables (Mertler et 
al., 2010). 
Three Factorial ANOVAs (Two-Factor Design) were performed. The first one  
evaluated if there were significant differences in newborn birthweight for gestational age 
between the mother‘s stress/anxiety scores (coded as high and low), and emotional 
lability scores (coded as high and low). The dependent quantitative variable was newborn 
birthweight; the independent categorical variables was stress/anxiety and emotional 
lability.  The second one evaluated if there were significant differences in newborn 
birthweight for gestational age between the mother‘s stress/anxiety scores (coded as high 
and low), and depression scores (coded as high and low). The dependent quantitative 
variable was newborn birthweight; the independent categorical variables were 
stress/anxiety and depression.  The third one  evaluated if there were significant 
differences in newborn birthweight for gestational age between the mother‘s depression 
scores (coded as high and low), and emotional lability scores (coded as high and low). 
The dependent quantitative variable was newborn birthweight; the independent 
categorical variables were depression and emotional lability.  
For the 2 x 2 factorial analysis, in which 4 groups were included, considering an effect 




36 participants. Considering a 10% of attrition, and additional 4 participants were added 
so that each group had at least 10 participants, and a total of 40 participants. 
For the factorial ANOVA results, a line plot  displayed factor interactions. If lines 
crisscrossed or overlapped, then an interaction was present. In order to evaluate if the 
interaction was statistically significant, the F ratio and the p level from the factorial 
ANOVA test was evaluated. 
Threats to Validity 
A possible threat to external validity in this study was the inclusion of mostly 
medium and low-income women because these are the patients attended at the 
Perinatology Institute.  High-income women in Mexico tend to receive medical care at 
private hospitals and this is why the study results may not be generalized to patients from 
all economical status. On the other hand, there is a known interaction between low 
birthweight for gestational age and preeclampsia, which may be independent from 
emotional factors which may pose a threat to internal validity; the interaction between 
infections and preterm birth may also be independent from emotional factors, thus may 
have affected internal validity of the study as well. 
Ethical Procedures 
Approval to perform this study was obtained from the Ethics and Research 
Committees at the National Institute of Perinatology in Mexico City, and Walden 
University’s Institutional Review Board (IRB) approval was also required. 
This study did not pose any potential physical or psychological harm for the 




approximately 35 minutes. Pregnant women received information regarding the nature of 
the study and the measurements characteristics. Participants were informed that their 
decision whether or not to participate in this study in no way affected their treatment at 
the Perinatology Institute, nor they would have had benefits for participating in the study. 
Each woman that agreed to participate  signed an informed consent letter that guaranteed 
her confidentiality. The informed consent stated that all records will remain confidential 
and only the researcher will have access to them. In order to maintain the confidentiality 
of the participants, all participants were assigned a study number and the names of the 
participants were only accessible to the main researcher.  The participants’ names were 
not  disclosed to others.   A copy of informed consent can be found in Appendix A.  
The MBMD and SSRQ results were available to all participants who wished to 
know their results, after pregnancy termination. Participants  let the researcher know this 
upon study enrollment and  contacted the researcher after delivery.  
Summary 
This was a prospective cross-sectional study that took place at the National 
Institute of Perinatology in Mexico City which included pregnant women from ages 18 to 
40 years old in any of the three trimesters of pregnancy. Participants were assessed at 
study enrollment and were followed until delivery. The study aimed to explore causal 
effects between emotional factors, specifically stress/anxiety, depression, and emotional 
lability, and pregnancy complications; and the effects of social support on emotional 
factors of pregnant women. At study enrollment, women  answered a demographical 




delivery, a second data collection took place in which the researcher  searched for 
pregnancy outcome information in the participant’s medical records.  
Three research questions were evaluated. The first one  evaluated the relationship 
between stress/anxiety, depression, and emotional lability with the development of 
preeclampsia, abruptio placentae, preterm birth, or low birthweight for gestational age. A 
logistic regression was performed for each dependent variable; controlling for the age of 
mother, the number of previous pregnancies, and the number of infections during 
pregnancy. The second research question was explored by performing a MANCOVA in 
which the relationship between social support and stress, depression, and social lability 
was evaluated. A factorial ANOVA was used to answer the third research question that 
considered if there were differences between birthweight of the offsprings of mothers 
who experienced high levels of anxiety or emotional lability, compared to those who not.  
All participants  signed an informed consent letter and were assigned a number 
upon study enrolment so all their information remained confident and the I was the only 
one who had access to it. 
The following chapter includes the results of this study. It explains the data 
collection process, the descriptive statistics and the results from the statistical analyses 




Chapter 4: Results  
Introduction 
The purpose of this study was to evaluate the effects of stress/anxiety, depression, 
and emotional lability on the development of pregnancy complications. For this matter, 
three research questions and hypotheses were proposed. The first hypothesis indicated 
that there is a significant relationship between stress/anxiety, emotional lability, and 
depression and the development of preeclampsia, abruptio placentae, preterm labor, and 
low birthweight for gestational age; the second hypothesis stated that the availability of 
social support has a significant relationship with the presence of stress/anxiety, emotional 
lability, and/or depression during pregnancy; the third hypothesis stated that there is a 
difference in newborn birthweight between pregnant women who experience high levels 
of stress/anxiety, depression, or high emotional lability scores during pregnancy  and 
those who do not. 
In this chapter, the results of the study are presented. The first part of the chapter 
describes the data collection process; it explains how many participants were included 
and the number of participants who were eliminated from the study due to incomplete 
data or the inability to evaluate their pregnancy outcomes. The second part of the chapter 
describes the demographic characteristics of the participants and includes their marital 
status, social income status, age at current pregnancy, gestational week at which the 
evaluation took place, and body mass index at the beginning of pregnancy. The third part 
of the chapter includes the descriptive statistics of the variables evaluated in this study, 




participants who developed preeclampsia, abruptio placentae, or preterm birth; and 
newborn’s weight, size, and Apgar scores. The last three parts of the chapter describe the 
data screening procedures that were performed before the analysis and the results of the 
statistical analyses performed. For Hypothesis 1, logistic regression analyses were 
performed; for Hypothesis 2, a MANCOVA was executed; for Hypothesis 3, three sets of 
factorial ANOVA were computed. 
Data Collection 
All participants were women attended at the National Institute of Perinatology in 
Mexico City. Two hundred eighty-one women were invited to participate; 11 women 
refused to participate, and 270 agreed to do so. From the 270 who participated, 16 did not 
complete the MBMD test appropriately and had to be eliminated. The remaining 254 
participants were followed until pregnancy termination, and the information regarding 
pregnancy outcomes was obtained from their medical records. Seven women did not 
deliver at the National Institutes of Perinatology and had to be located by phone or email 
to obtain information regarding pregnancy termination and newborn variables. Three of 
the seven women who did not deliver at the National Institute of Perinatology could not 
be found. From the 251 participants whose information was gathered at pregnancy 
termination, nine participants had to be eliminated because of missing data for some 
variables. The total number of participants who had a complete evaluation at study 
enrollment and complete pregnancy outcome information was 242. The first stage of the 
data collection process, which was the recruitment and evaluation of participants, lasted 2 




to pregnancy outcomes and newborn conditions were obtained from the medical records, 
lasted 3.5 months. 
Demographics Results 
The study included 242 pregnant women ranging in age from 18 to 43, with a 
mean age of 29.59 and a standard deviation of 6.85. The mean evaluation week was 
31.54, with a standard deviation of 5.10. The mean number of pregnancies for 
participants was 2.42 (1.39). The body mass index mean prior to current pregnancy was 
25.91 (5.17). The mean height for participants was 1.58 meters, with a standard deviation 
of 0.06 (see Table 1). 
Table 1 











Mean 29.59 31.54 2.42 25.9126 1.5800 
Median 29.50 32.00 2,00 24.9000 1.5800 
SD 6.86 5.103 1.39 5.17279 .06996 
Minimum 18 21 1 17.10 1.30 
Maximum 43 40 8 51.51 1.81 
 
 Regarding the social status of participants, as shown in Table 2, 43.8% of 
participants were married, 21.5% were single, and 34.7% were in a relationship. Of the 
242 participants, 232 had a monthly family income that ranged from 1 to 10,000 Mexican 




that ranged between 11,000 and 84,000 Mexican pesos, considered as medium income. 
No high-income participants were included in this study (see Table 2). 
Table 2 
Social Status and Monthly Family Income 
 Frequency Percent 
Social status Married 106 43.8 
Single 52 21.5 
In a relationship 84 34.7 
Total 242 100.0 






 Total 242 100.0 
 
Descriptive Statistics 
Cesarean-section was the most common method of delivery, accounting for 
76.9%. The remaining 23.1% had vaginal deliveries. Low-weight for gestational age was 
present in 15.3% of delivered babies, whereas 4.5% were considered as hypertrophic. The 
rest of the babies born from participants, 80.2%, had normal weight for gestational age 










Newborn Weight for Gestational Age 
 




Low Weight 37 15.3 15.3 15.3 
Normal Weight 194 80.2 80.2 95.5 
High Weight 11 4.5 4.5 100.0 
Total 242 100.0 100.0  
 
As the National Institute of Perinatology is considered a concentration hospital for 
high-risk pregnancies, many participants had comorbidities. The most common illnesses, 
as shown in Table 4, were type 2 diabetes in 5.8%, gestational diabetes in 14.9%, 
hypothyroidism in 10.7%, cardiopathy in 2.5%, epilepsy in 2.9%, asthma in 2.5%, and 
drug use in 2.5% of participants. Of the 242 women evaluated, fifteen women developed 
preeclampsia, 37 women delivered preterm, and four women had premature abruption of 
the placenta. Results are presented in Table 5.  
Table 4 
Maternal Illness 
 Frequency Percent 
None 106 43.8 
Diabetes mellitus 1 2 0.8 
Diabetes mellitus 2 14 5.8 
Gestational diabetes 36 14.9 
Hyperthyroidism 4 1.7 
Hypothyroidism 26 10.7 
Arthritis 1 0.4 
Lupus 2 0.8 




 Frequency Percent 
Cardiopathy 6 2.5 
Fibromyalgia 1 0.4 
Asthma 6 2.5 
Psychopathology 4 1.7 




Epilepsy 7 2.9 
Placental acretism 3 1.2 
Bulimia 1 0.4 
Thrombocytopenia 1 0.4 





Myasthenia gravis 1 0.4 
Uterine myomatosis 2 0.8 
Scleroderma 1 0.4 




Vitiligo 1 0.4 
Bone dysplasia 1 0.4 
Atopic dermatitis 1 0.4 
McCune Albright 1 0.4 
Erythema nodoso 1 0.4 
Hepatopathy 1 0.4 











 Frequency Percent 
 Preeclampsia 15 6.2 
Preterm birth 37 15.3 
Abruptio placentae 4 1.7 
None of the above 186 76.8 
Total 242 100.0 
 
Psychosocial Factors 
Total social support scores for participants had a mean of 15.88, with 54 being the 
maximum score possible in the SSQ. The mean for social support satisfaction scores was 
32.32, 36 being the maximum score possible. The mean of the overall total social support 
score obtained through the SSQ from participants was 48.20, with 90 being the maximum 
achievable score. Total social support scores were divided into four categories, as shown 
in Table 6. Two percent of participants had low social support, 40.9% had medium-low 
social support, 50% had medium-high social support, and 6.6% of participants had high 
social support.  
The mean score for stress/anxiety was 66.36, the mean depression score was 
54.70, and the mean score for emotional lability was 59.71. The maximum possible score 
for these three variables was 100 (see Table 7). According to the MBMD manual (Millon 
et al., 2006), scores between 60 and 74 are suggestive but not sufficiently indicative of 
symptom pathology; scores of 75 to 84 suggest the presence of the disorder; and scores of 















Mean 66,36 54.70 59.71 
Median 71,50 64.00 62.00 
SD 23,97 28.84 16.21 
Minimum 5 5 10 
Maximum 105 105 95 
 
Preanalysis Data Screening 
Before performing multivariate analysis, I screened the data for outliers. 
Normality, linearity, and homoscedasticity were evaluated. Univariate screening for 
outliers of grouped data with stem and leaf plots was performed, but no outliers were 
eliminated. Multivariate screening for ungrouped data was performed for 14 numerical 
variables using Mahalanobis distance. Considering that the critical value for X2 at p < 
0.001 with 14 degrees of freedom is 36.123, I eliminated cases with a Mahalanobis 
Categories of Total Social Support  
 Frequency Percent 
 







High social support 16 6.6 




distance greater than 36.123 from further analysis. Eight cases were eliminated in this 
process. Thus, for multivariate analyses, 234 cases were included. 
To evaluate univariate normality, histograms, Q-Q plots, skewness, kurtosis, and 
Kolmogorov-Smirnov tests of normality were performed for numerical variables. 
Levene’s test for equality of variances showed homogeneity of variances because no 
values were significant. Lastly, homogeneity of variance-covariance matrices was 
evaluated within MANOVA by calculating Box’s test of equality of variance. As Box’s 
test was not significant, equality of covariance was concluded. 
Hypothesis 1 Results 
Logistic Regression Analysis for Preeclampsia  
An Enter logistic regression was conducted to evaluate which independent 
variables (maternal age, social status, family income, total social support, stress/anxiety, 
depression, and emotional lability) were predictors of preeclampsia. A 95% confidence 
interval was used. Data screening led to the elimination of eight outliers. Logistic 
regression results showed that the overall model fit of eight predictors was moderate (-
2log Likelihood = 105.075), but the model was not statistically reliable to distinguish 
between preeclampsia and nonpreeclampsia  (X2(8) = 6.360, p = 0.07). The model 
correctly classified 93.6% of the cases. Wald statistic showed that being single 
significantly predicts preeclampsia in this model. Regression coefficients are presented in 







Regression Coefficients for Preeclampsia  
 B Wald df p OR 
Maternal age 0.019 0.198 1 0.657 1.020 
Married 0.462 0.385 1 0.535 1.587 
Single 1.504 3.906 1 0.048 4.498 
Family income -0.691 0.363 1 0.547 0.501 
Stress/anxiety -0.003 0.043 1 0.837 0.997 
Depression 0.014 1.341 1 0.247 1.014 
Emotional lability 0.001 0.001 1 0.979 1.001 
Social support 0.025 1.014 1 0.314 1.025 
Constant -5.076 3.643 1 0.056 0.006 
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval. 
 
Logistic Regression Analysis for Preterm Birth 
A logistic regression was conducted to evaluate which independent variables 
(maternal age, social status, family income, total social support, stress/anxiety, 
depression, and emotional lability) were predictors of preterm birth. Data screening led to 
the elimination of eight outliers. Logistic regression results showed that the overall model 
fit of eight predictors was fair (-2log Likelihood = 189.511), but the model was not 
statistically reliable to distinguish between preterm birth and nonpreterm birth (X2 (8) = 
14.789, p = 0.063). The model correctly classified only 84.2% of the cases. Wald statistic 
showed that the variables single and social support significantly predict preterm birth in 
this model. Regression coefficients are presented in Table 9. The odds ratio for the 
variable single indicates increased likelihood of preterm birth development. However, the 






Regression Coefficients for Preterm Birth  
 B Wald df p OR 
Maternal age 0.021 0.516 1 0.473 1.021 
Married 0.316 0.596 1 0.440 1.371 
Single 1.396 4.340 1 0.037 4.041 
Family income 0.602 0.470 1 0.493 1.826 
Stress/anxiety -0.019 2.673 1 0.102 0.981 
Depression -0.003 0.155 1 0.694 0.997 
Emotional lability 0.017 1.160 1 0.282 1.017 
Social support -0.043 5.517 1 0.019 .957 
Constant 2.761 2.120 1 0.145 15.816   
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval. 
 
Logistic Regression Analysis for Abruptio Placentae  
A logistic regression was conducted  to evaluate which independent variables 
(maternal age, social status, family income, total social support, stress/anxiety, 
depression, and emotional lability) were predictors of abruptio placentae. Data screening 
led to the elimination of eight outliers. Logistic regression results showed that the overall 
model fit of 8 predictors was good (-2log Likelihood = 28.657) but the model was not 
statistically reliable to distinguish between abruptio placentae and non-abruptio placentae 
(X2 (8) =  11.826, p = 0.159). The model correctly classified 98.3% of the cases. Wald 
statistic showed that the family income significantly predicts abruptio placentae in this 
model. Regression coefficients  are presented in Table 10.  Odds ratio for the variable 







Regression Coefficients for Abruptio Placentae  
 B Wald df p OR 
Maternal Age -0.027 0.089 1 0.766 0.973 
Married -16.580 0.000 1 0.997 0.000 
Single -17.999 0.000 1 0.996 0.000 
Family income 3.260 4.071 1 0.044 26.044 
Stress/Anxiety -0.112 2.824 1 0.093 0.894 
Depression 0.009 0.120 1 0.729 1.010 
Emotional Lability 0.073 1.521 1 0.217 1.075 
Social Support 0.016 0.088 1 0.767 1.017 




Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval. 
 
Logistic Regression Analysis for Low Weight for Gestational Age  
A logistic regression was conducted  to evaluate which independent variables 
(maternal age, social status, family income, total social support, stress/anxiety, 
depression, and emotional lability) were predictors of low-weight for gestational age. 
Data screening led to the elimination of eight outliers. Logistic regression results showed 
that the overall model fit of 8 predictors was poor (-2log Likelihood = 192.570) and the 
model was not statistically reliable to distinguish between low-weight for gestational age 
and non-low-weight for gestational age (X2(8) = 4.910, p = 0.767). The model correctly 
classified 85% of the cases. Wald statistic showed that the variables entered in the model 
do not significantly predict low-weight for gestational age. Regression coefficients  are 






Regression Coefficients for Low Weight for Gestational Age  
 B Wald df p OR 
Maternal Age -0.001 0.001 1 00.95 .999 
Married 0.649 2.055 1 0.152 1.914 
Single 0.327 0.344 1 0.558 1.387 
Family Income 0.236 0.045 1 0.832 1.266 
Stress/Anxiety 0.013 1.383 1 0.240 1.013 
Depression -0.006 0.698 1 0.403 0.994 
Emotional Lability -0.017 1.246 1 0.264 0.983 
Social Support 0.007 0.146 1 0.702 1.007 
Constant -2.194 1.198 1 0.274 0.111 
Note. OR = odds ratio; df = degrees of freedom; CI = confidence interval. 
 
Hypothesis 2 Results 
MANCOVA Results 
Multivariate analysis of covariance (MANCOVA) was performed to determine 
the effect of social support category on stress/anxiety, depression, and emotional lability 
scores while controlling for maternal age at time of pregnancy and number of 
pregnancies. Prior to the test, outliers were eliminated.  MANCOVA results revealed a 
significant difference among the social support categories on the combined dependent 
variables, Pillai’s Trace  = 0.018, F (9,684) =  3.125, p = 0.001, multivariate n2 = 0.39. 
The covariates (maternal age and  number of pregnancies) did not significantly influence 
the combined dependent variables. Analysis of covariance (ANCOVA) was conducted on 
each dependent variable as a follow-up test to MANCOVA. Results are shown in Table 




on the combined dependent variables, the ANCOVA reported significant differences 
between number of pregnancies and stress scores [F (3,228) =  5.893 , p =  0.016, partial 
n2=  0.025]. 
Table 12 
ANCOVA Summary Table for Social Support on Stress/Anxiety, Depression, and 
Emotional Lability 
Source DV SS df MS F p n2 
Social Support Stress/Anxiety 5876.63 3 1958.88 3.762 0.012 0.047 
Depression 20075.75 3 6691.92 9.050 0.000 0.106 
EL 677.03 3 225.67 0.842 0.472 0.011 
Maternal Age Stress/Anxiety 1282.01 1 1282.01 2.462 0.118 0.011 
Depression 451.22 1 451.22 0.610 0.436 0.003 
EL 301.34 1 301.34 1.124 0.290 0.005 
No. pregnancies Stress/Anxiety 3068.47 1 3068.47 5.893 0.016 0.025 
Depression 1850.76 1 1850.76 2.503 0.115 0.011 
EL 237.52 1 237.52 .886 0.348 0.004 
Within 
Treatments 
Stress/Anxiety 118710.63 228 520.66    
Depression 168596.57 228 739.46    
EL 61113.78 228 268.04    
Total Stress/Anxiety 1152572.00 234     
Depression 896691.00 234     
 EL 891525.00 234     
Corrected Total Stress/Anxiety 130097.54 233     
 Depression 193782.35 233     
 EL 62392.35 233     
Note. DV = dependent variable; df = degrees of freedom; SS = sum of squares; MS = 
mean of squares; EL = emotional lability. 
 
A comparison of adjusted means show that there is a difference of 19.51 points in 
stress/anxiety scores between medium-low social support and high social support and a 




high social support . Table 13 presents adjusted and unadjusted means for stress/anxiety, 
depression and emotional lability by social support category. 
Table 13 








Stress/Anxiety Low 68.137a 9.318 
Medium-low 71.125a 2.349 
Medium-high 63.632a 2.107 
High 51.607a 6.158 
Depression Low 62.645a 11.105 
Medium-low 64.835a 2.799 
Medium-high 48.830a 2.511 
High 33.075a 7.338 
Emotional Lability Low 59.289a 6.686 
Medium-low 61.282a 1.685 
Medium-high 58.678a 1.512 
High 54.728a 4.418 
Note. Covariates appearing in the model are evaluated at the following values: 
Maternal Age = 29.53, No. Pregnancies = 2.42. 
 
Hypothesis 3 Results 
Three sets of factorial ANOVA were performed to evaluate the effects of 
stress/anxiety, depression and emotional lability on newborn weight, and  the possible 
interaction effects among them. 
Factorial ANOVA Stress/Anxiety, Emotional Lability, and Birthweight 
Data were  screened to ensure that assumptions of factorial ANOVA were met.  





Table 14  
Descriptive Statistics on Interactions Between Stress and Emotional Lability 
With Newborn Weight as Dependent Variable 
Stress Emotional Lability Mean SD N 
Low 
Low 3013.19 536.504 31 
High 2982.78 565.585 27 
Total 2999.03 545.564 58 
High 
Low 2903.50 559.677 22 
High 2865.38 448.847 154 
Total 2870.15 462.477 176 
Total 
Low 2967.66 543.634 53 
High 2882.90 468.197 181 
Total 2902.09 486.381 234 
 
In order to identify interaction effects between factors,  line plots of the cell 
means were performed. Line plots of  Stress/Anxiety and Emotional Lability variables 
show no interaction between factors. Lines show that higher levels of stress are related 













Figure 2. Interaction of emotional lability and stress/anxiety on newborn weight. 
 
A 2X2 factorial analysis of variance was performed to investigate newborn 
birthweight differences  in stress and depression category among pregnant women.  
Test’s results in Table 15 show that newborn weight is not significantly different in 








ANOVA Summary Table for  Stress/Anxiety and Depression on Newborn Weight 
Source SS df MS F p n2 
Between treatments 765990.53a 3 255330.18 1.080 00.38 0.014 
Stress 425335.81 1 425335.81 1.800 0.181   0.008 
Emotional Lability 38738.06 1 38738.06 0.164 00.66 0.001 
Stress x EL 489.16 1 489.160 0.002 00.964 0.000 
Within treatments 54354023.40 230 236321.84    
Total 2025903040.00 234     
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares: EL = 
emotional lability 
 
Factorial ANOVA Stress/Anxiety, Depression, and Birthweight 
Data were  screened to ensure that assumptions of factorial ANOVA were met.  
Univariate and multivariate outliers were evaluated and eight outliers were eliminated. 
Means and standard deviations were calculated for all variables before checking 
interactions (see Table 16). 
Table 16 
Descriptive Statistics on Interactions Between Stress and 
Depression With Newborn Weight as Dependent Variable 
Stress Depression Mean SD N 
Low 
Low 2929.41 541.824 44 
High 3217.86 515.764 14 
Total 2999.03 545.564 58 
High 
Low 2801.50 498.600 42 
High 2891.66 450.373 134 
Total 2870.15 462.477 176 
Total 
Low 2866.94 522.077 86 
High 2922.52 464.993 148 





In order to identify interaction effects between factors,  line plots of the cell 
means were performed. The line plots of  Stress/Anxiety and Depression show interaction 
between factors. Lines show that high stress scores are related to lower birthweight, but 
low stress scores combined with high depression scores, are not related to low weight for 
gestational age (see Figure 3). 
 










Figure 4. Interaction of stress/anxiety and depression on newborn weight. 
 
A 2X2 factorial analysis of variance was performed to investigate newborn 
birthweight differences  in stress and depression category among pregnant women. 
ANOVA results, presented in Table 17, show a significant main effect of stress  
[F(1,230) =  7.10 , p =  0.008, partial n2 =  0.030],  and depression [F(1,230) =  4.94 , p =  
0.027, partial n2=  0.021]. Interaction between factors was not significant [F(1,230) =  







ANOVA Summary Table for Stress/Anxiety and Depression on Newborn Weight  
Source SS df MS F p n2 
Between treatments 1868299.193 3 622766.40 2.690 0.047 0.034 
     Stress 1644039.50 1 1644039.50 7.101 0.008    0.030 
     Depression 1142864.11 1 1142864.11 4.936 0.027 0.021 
     Stress x Depression 313458.53 1 313458.53 1.354 0.246    0.006 
Within treatments 53251714.739 230 231529.195    
Total 2025903040.00 234     
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares; EL = 
emotional lability 
 
Factorial ANOVA Depression, Emotional Lability, and Birthweight 
Data were  screened to ensure that assumptions of factorial ANOVA were met.  
Univariate and multivariate outliers were evaluated and eight outliers were eliminated. 
Means and standard deviations were calculated for all variables before checking 














Descriptive Statistics on Interactions Between Depression and Emotional 
Lability With Newborn Weight as Dependent Variable 
Depression Emotional Lability Mean SD N 
Low Low 2865.83 552.14 35 
High 2867.71 506.01 51 
Total 2866.94 522.08 86 
High Low 3165.67 481.05 18 
High 2888.85 454.42 130 
Total 2922.52 464.99 148 
Total Low 2967.66 543.63 53 
High 2882.90 468.20 181 
Total 2902.09 486.38 234 
 
In order to identify interaction effects between factors,  line plots of the cell means were 
performed. Intersection of lines shows  interaction between depression and emotional 
lability. Lines show that higher levels of  depression combined with high levels  of 












Figure 6. Interaction of depression and emotional lability on newborn weight. 
 
A 2X2 factorial analysis of variance was performed to investigate newborn 
birthweight differences  in stress and depression category among pregnant women. 
ANOVA results, presented in Table 19, show a significant main effect of depression on 
newborn weight [F(1,230) =  3.96 , p =  0.048, partial n2=  0.017] but not for emotional 
lability [F(1,230) =  2.90 , p =  0.090, partial n2 =  0.012].  Estimates of effect size 
revealed low strength in associations.  No post hoc tests were performed because the 
variables depression and stress/anxiety only have 2 categories. Results show that 






ANOVA Summary Table for Emotional Lability and Depression on Newborn 
Weight  
Source SS df MS F p n2 
Between treatments 1379600.15 3 459866.72 1.968 0.120 0.025 
     Depression 924658.524 1 924658.52 3.957 0.048 0.017 
     Emotional Lability 678376.362 1 678376.36 2.903 0.090 0.012 
     Depression x EL 697031.198 1 697031.20 2.983 0.085 0.013 
Within treatments 53740413.783 230 233653.97    
Total 2025903040.00 234     
Note. df = degrees of freedom; SS = sum of squares : MS = mean of squares; EL = 
emotional lability 
Summary 
 The results of this study were obtained by performing statistical analyses to a 
database that was made through the evaluation of patients from the National Institute of 
Perinatology in Mexico City.  This study included a population constituted mostly by 
low-income pregnant women. Different statistical tests were used to explore the 
hypotheses and research questions of the study. 
The logistic regression models for Hypothesis 1 were not statistically reliable to 
distinguish between the two categories of dependent variables that were evaluated. 
However, some statistically significant differences were found in some models.  The 
alternative Hypothesis 2 was supported by this research because the amount of social 




The results for Hypothesis 3 show that stress and depression have significant effects on 
newborn weight, and high stress scores are related to lower newborn weight. 
In chapter 5, an overview of the research study and the results is presented. The 
findings are discussed in this chapter, as well as the implications for social change of this 
study. This manuscript concludes with the researcher’s point of view of the findings of 





Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
This study was performed to evaluate the effects of psychosocial factors on the 
development of pregnancy complications or poor pregnancy outcomes, such as 
preeclampsia, preterm birth, abruptio placentae, and low weight for gestational age. In 
this study, I also sought to determine if the amount of social support may influence 
stress/anxiety or depression levels in pregnant women. Additionally, I aimed to determine 
whether there is a relationship between stress, depression, and emotional lability and 
newborn weight.  
Given that the current study involved obtaining information from a cohort of 
pregnant women who were followed until delivery, the participants included in this study 
were women in the second or third trimester of pregnancy. Although the inclusion of 
women in the first trimester of pregnancy would have been appropriate, these women 
were not invited to participate because this would have prolonged the time for study 
completion by 3 months. 
This prospective study was done thanks to the participation of patients from the 
National Institute of Perinatology, who kindly spent approximately 35 minutes of their 
time answering the demographic questionnaire, the MBMD test, and the SSQ.  
Previous research has focused on the effects of stress and depression on the 
development of pregnancy complications, mainly preterm birth and small-for-gestational-




emotional lability in pregnancy. Moreover, there are no reported studies regarding stress, 
depression, and emotional lability on pregnancy outcomes in the Mexican population. 
Overview 
Women in the second and third trimesters of pregnancy were evaluated and 
followed until delivery.  All participants were patients from the National Institute of 
Perinatology. This is the biggest public perinatology hospital in Mexico City, where more 
than 100 pregnant women are attended every day. Two hundred eighty one women were 
invited to participate, and only 11 women refused to do so. Thus, the study initially had 
270 participants. The first stage of the data collection process, which was the recruitment 
and evaluation of participants, lasted 2 months. After this time, all women were followed 
until delivery. Following pregnancy termination, several variables related to pregnancy 
outcomes and newborn conditions were obtained from the medical records. This was the 
second phase of the data collection process, which lasted 3.5 months. After eliminating 
those participants who did not complete correctly the MBMD test and those who did not 
deliver at the National Institute of Perinatology and were not able to be reached by me, I 
had a total of 242 participants with complete information for analysis. As the required 
sample to have a power of 0.80 was not achieved, the power of this study with 242 
participants was 0.74, considering an alpha level of 0.05.  
Demographics of the Study Population 
The patients who receive healthcare at the National Institute of Perinatology come 
from different parts of the country, but most of the study participants were women living 




evaluation was 29.59 +-6.85 years.  The mean number of pregnancies for participants was 
2.42+-1.39. The mean of the body mass index before pregnancy in evaluated patients was 
25.91(5.17). The results of this study show that we may also have a problem of increased 
weight in the childbearing population, as 49.6% of the women evaluated were overweight 
or obese. Although the relationship between BMI and depression or stress scores was not 
directly evaluated in this study, it would be an interesting association to search for in 
future studies. It has been reported that high BMI may increase obstetrical risks (Chu et 
al., 2008).  
This study mainly evaluated low-income women because 95.9% of participants 
were of low socioeconomic status and the remaining 4.1% of women were from medium 
socioeconomic status.  No women from high-income families participated in this study. 
Low socioeconomic status families in Mexico earn from 0 to 10,000 Mexican pesos per 
month, which is a monthly income below 850 US Dollars.  
Almost half of the participants (43.8%) were married, 34.7% were in a 
relationship and living with the father of the baby, and the remaining 21.5% were single 
and had no relation with the father of the baby at the moment of evaluation. 
Mean gestational age at delivery was 38.19 weeks. The statistical analysis for the 
present study did not evaluate correlations between stress and depression scores and 
gestational age at delivery, but this will be done in a future study. The mean newborn 
height was 48.70 cm (1.54), and the mean weight of newborns was 2904 grams (488.67). 
Babies born in Mexico City tend to be smaller than those born in lower altitude zones in 




classify the newborn’s weight into low, normal, or high weight for gestational age (Flores 
Huerta & Martínez Salgado, 2012). According to these indexes, 15.3% of newborns had 
low weight for gestational age because their weight was below the 10th percentile, while 
80.2% had normal weight and 4.5% had high weight for gestational age, with a weight 
above the 90th percentile. 
From the 242 participants in this study, 136 participants had associated 
pathologies and 106 were healthy. The most common pathologies present in these women 
were type 2 diabetes, gestational diabetes, hypothyroidism, asthma, epilepsy, and 
cardiopathy. No correlations were evaluated in this study between these pathologies and 
pregnancy outcomes, nor were they included as covariates. 
Three types of social support scores were obtained with the SSQ: the social 
support network score, social support satisfaction score, and overall social support score. 
The social support network scores obtained by participants in the SSQ had a mean of 
15.88 (9.08). Given that the maximum score for social support network in Sarason’s 
questionnaire is 54, the social support network that many of these pregnant women could 
count on was quite small. Regarding social support satisfaction, the mean score was 
32.32 (6.59). As the maximum score possible for satisfaction in the SSQ is 36, results 
show that although some participants might not have had big social support networks, 
many were satisfied with the social support received. The overall social support scores 
for participants had a mean of 48.20 (12.07), with 90 being the maximum achievable 
score. This shows that the overall social support mean for the study group was not high, 




Total social support scores were divided into four categories for further analysis. 
Low social support was present in 2.5% of participants and medium-low social support 
was found in 40.9%, whereas medium-high social support was present in 50% of 
participants and high social support was present in 6.6%. Medium social support was 
present in more than 80% of participants. 
Stress/anxiety scores had a mean of 66.36 (23.97), and the mean for depression 
scores was 54.70 (28.84). Emotional lability scores had a mean of 59.71 (16.20). 
Stress/anxiety scores were the highest among the three variables. Between these three 
variables, stress was the variable with the highest mean. Women in this study had higher 
stress/anxiety and depression scores than those obtained with the MBMD in patients with 
severe and moderate asthma (Lavoie et al., 2010) and had higher stress/anxiety and 
emotional lability scores than those found in HIV-positive men and women (Cruess, 
Minor, Antoni, & Millon, 2007). 
Frequency of Pregnancy Complications 
The incidence of preeclampsia in this study was 6.2%, which is within the 
reported frequency for preeclampsia in the general population. As preeclampsia has an 
incidence that ranges from to 2-6% (Chappell et al., 2008), the population studied did not 
have increased prevalence of this syndrome. 
Of the 15 women who developed preeclampsia, seven delivered preterm, being 
considered as early onset preeclampsia, and eight delivered after week 37, considered as 
late onset preeclampsia. No statistical analyses to differentiate between early onset and 




Preterm birth was the most common pregnancy complication found in this study, 
accounting for 15.3%, with 37 cases. As the reported prevalence for preterm birth in the 
general population is 5-10% (Dayan et al., 2006), an increased incidence of preterm birth 
was found in the population studied. This may have been due to the type of population 
studied, as the National Institute of Perinatology attends women who have comorbities 
during pregnancy. 
The less common pregnancy complication that was evaluated in this study was 
abruptio placentae. Only four women had premature abruption of the placenta, 
representing 1.7% of cases. 
Interpretation of Hypothesis 1 Findings 
Factors increasing risk for preeclampsia.  A logistic regression was performed 
to evaluate factors predicting the development of preeclampsia. The overall model fit was 
moderate. However, in the analysis, the Wald statistic indicated that being a single 
mother significantly predicts preeclampsia with an OR = 4.49 (CI 1.01-19.98). Stress and 
depression scores were not significant as predictors for preeclampsia in this model. Thus, 
the first alternative hypothesis, which stated that stress, depression, or emotional lability 
influence the development of preeclampsia, was not supported by this study. However, 
the finding that being single can increase the risk of developing preeclampsia is relevant 
because single marital status has been reported as a risk factor, mostly for preterm birth 
(Shah, Zao, & Ali, 2011), but not for preeclampsia. Perhaps being single affects the 
development of preeclampsia  through pathways different from those of stress and 




were not measured in this study. On the other hand, low socioeconomic status has been 
considered a risk factor for preeclampsia (Silva et al., 2008), but in this study, family 
income was not significant for the development of preeclampsia. The fact that the 
majority of participants in this study were from low-income families may have influenced 
the results on this matter because there was not a high income population for comparison. 
Factors increasing risk for preterm birth. A logistic regression was performed 
in order to evaluate predictor variables for preeclampsia. The overall model fit was fair, 
and the Wald statistic showed that two variables were significant for preterm birth in this 
model: being single, OR = 4.04, 95% CI [1.08, 15.03], and social support, OR = 0.95, 
95% CI [0.92, 0.99]. For social support, the OR is below 1. Thus, social support reduces 
by 5% the risk for preterm birth. In contrast, stress and depression scores were not 
significant as predictors for preterm birth in this model; this result is similar to those of 
other studies that did not find an association between stress and depression and preterm 
birth (Berle et al., 2005). 
The results from this analysis regarding social status and social support are similar 
to those of other studies. Maternal unmarried social status was associated in a meta-
analysis with increased risk of preterm birth (Shah et al., 2011), and Ancel et al. (1999) 
also found increased risk for preterm birth in unmarried cohabiting and unmarried 
noncohabiting women (Ancel, Saurel-Cubizolles, Renzo, Papiernik, & Bréart, 1999).  
Finding a small but protective effect of social support on the development of 
preterm birth in this study is relevant because social support has been reported to improve 




considered an important risk factor for preterm birth (Elsenbruch et al., 2007). However, 
according to the results in this study, the association between social support and lower 
risk for preterm birth may not be through the stress-buffering effects of social support in 
these patients, as stress and depression were not significant predictors of preterm birth in 
this study. On the other hand, it may be that higher levels of social support decrease stress 
scores in such a way that stress no longer acts as a predictor variable for preterm birth. 
Further studies are needed in order to clarify these concepts and explain the pathways by 
which the presence or the lack of social support may affect pregnancy outcomes .  
Lastly, it must be noted that eight patients who developed preeclampsia also 
delivered preterm. Even though patients with early onset preeclampsia are at higher risk 
of delivering preterm because preeclampsia develops before week 34 of gestation, it is 
relevant that single maternal status was related to both preeclampsia and preterm birth as 
a predicting factor. These findings may have important implications not only for social 
workers, but also for clinicians, and they may help gain a broader perspective on the 
importance of being accompanied and cared for during the gestational period. 
Factors increasing risk for abruptio placentae. A logistic regression was 
performed to evaluate factors predicting the development of abruptio placentae. The 
overall model fit was moderate, and the model was not statistically reliable to distinguish 
between abruptio placentae and non-abruptio placentae. However, one significant 
variable was found in the model that included seven independent variables. Family 





Although low family income may increase the risk of low weight for gestational 
age babies and preterm birth (Parker, Schoendorf, & Kiely, 1994), it is not a common risk 
factor reported for abruptio placentae. Known risk factors for abruptio placentae are 
multigravidity and folic acid deficiency (Hibbard & Hibbard, 1963). 
The finding that low income may act as a predictor for abruptio placentae could 
have been promoted by the high prevalence of low-income families evaluated in this 
study, which may also explain the high variability in the confidence interval for this 
variable. Further studies that include a higher number of cases with abruptio placentae 
may be needed. 
Factors increasing risk for newborns with low weight for gestational age. A 
logistic regression was performed to evaluate factors predicting the delivery of low 
weight for gestational age newborns (SGA). The overall model fit was poor, and no 
variables were found to be statistically significant as predictors of low weight for 
gestational age in this model. This may have been due to low sample size or to a poor 
model fit, because other studies have found increased risk for SGA and low family 
income (Parker et al., 1994), for maternal unmarried status (Shah et al., 2011), and for 
maternal depression (Stewart, 2007). Although no statistical differences were found in 
this regression model, it is believed that fetal growth and newborn weight can be 
predicted by the amount of maternal social support (Feldman et al., 2000).  
Interpretation of Hypothesis 2 Findings 
Impact of Social Support on Stress and Depression. A MANCOVA was 




stress/anxiety, depression and emotional lability, controlling for maternal age and number 
of pregnancies. Results showed that stress/anxiety scores and depression scores are 
significantly influenced by social support levels, being the effect size of depression 
higher (partial n2 = 0.106) than that of stress/anxiety (partial n2 = 0.047).  The small 
number of participants in the low social support group (n = 6) may explain the lack of 
statistical differences for this group. Results indicate that higher levels of social support 
are associated with lower levels of depression and lower levels of stress/anxiety in 
pregnant women. 
Social support is believed to affect well-being by potentially protecting the 
adverse effects of stress (Cohen & Wills, 1985). Hoffman et al (1996) emphasize the 
importance of social support on improving pregnancy outcomes because it may have 
direct buffering effects on stressors (Hoffman et al., 1996). In this study, social support 
does appear to have buffering effects on stress levels, and, more importantly, on 
depression scores. The finding that social support can have direct implications on 
depression scores in pregnant women is interesting because social support has mainly 
been attributed a stress-buffering effect but not a depression-buffering effect. The second 
alternative hypothesis, which stated that availability of social support has a significant 
relationship with the presence of stress/anxiety and/or depression during pregnancy was 
supported by this study.  
According to the results, not only social support scores may influences stress 




This finding may help healthcare providers comprehend how emotional factors may 
affect women during  first time pregnancy.   
Interpretation of Hypothesis 3 Findings 
Impact of Stress/Anxiety, Depression and Emotional Lability on Newborn 
Weight. Three sets of factorial ANOVA were performed to evaluate the impact of 
stress/anxiety, depression and emotional lability on newborn weight. 
Results of the 2X2 factorial analysis of variance to evaluate the effect of stress 
and emotional lability showed that newborn weight is not significantly different in 
women with low and high levels of stress and low and high levels of emotional lability. 
Line plots of the variables stress/anxiety and emotional lability show no interaction 
either. Although the effect of these variables on newborn weight it is not statistically 
significant, lines show that higher levels of stress and emotional lability are related to 
lower newborn weight than low stress and low emotional lability.  
Results of the 2X2 factorial analysis of variance to evaluate the effect of stress 
and depression showed that newborn weight is significantly different in women with low 
and high levels of stress and low and high levels of depression. Although factorial 
analysis did not show a statistically significant combined effect of stress and depression 
on newborn weight, line plots of the variables stress/anxiety and depression show 
interaction between factors. High  stress scores combined with high depression scores are 
related to lower newborn weight. 
These results support the concept that stress and depression can affect newborn 




and severe life events can be associated to low birthweight (Khashan et al., 2008; Rondo 
et al., 2003). However, other researchers have not found an association between stress 
and depression with low birth weight (Berle et al., 2005; Brooke, Anderson, Bland, 
Peacock, & Stewart, 1989). The finding that stress and depression scores can affect 
newborn weight has relevant implications because it is highly probable that this may due 
to the participation of neuroendocrine pathways that are affecting either fetal nutrient 
availability or affecting fetal endocrine  mechanisms. Unfortunately, no biomarkers were 
measured in this study to be able to correlate them with stress, depression scores and 
newborn weight. According to the line plots, the presence of high stress scores and low 
depression scores may be related to lower newborn weight than high depression, and low 
stress scores. This implies that high stress scores are the ones related to lower newborn 
weight. 
Results of the 2X2 factorial analysis of variance to evaluate the effect of 
emotional lability and depression showed that newborn weight is significantly different in 
women with low and high levels of depression. 
Although the combined effect of emotional lability and depression on newborn 
weight was not statistically significant in factorial analysis, line plots of the variables 
emotional lability and depression show interaction among variables. High levels of 
depression scores combined with high levels of emotional lability are related to lower 
newborn weight. Low levels of depression combined with low levels of emotional lability 




The results supported the finding that increased maternal depression can be 
related to low-weight for gestational age because it can affect infant growth (Nasreen et 
al., 2010; Stewart, 2007). Stress and low social support have been related to emotional 
lability in pregnancy (Norbeck et al., 1983), but the effects of emotional lability on 
pregnancy outcomes has not been  fully studied. This study did not find an association 
between emotional lability and newborn weight.  
Implications for Social Change and Recommendations for Action 
As being a single mother may increase the probability of developing preterm birth 
and preeclampsia in low-income Mexican women, social workers from the National 
Institute of Perinatology should take special care of those single women being attended at 
this hospital. Even though the study was not able to indicate by what mechanisms being 
single could increase the probabilities of developing preterm birth or preeclampsia, it 
could be related to decreased amount of social support in these women and, perhaps, 
higher levels of stress or allostatic load. The creation of social support groups at this 
perinatology hospital would be relevant for these patients.  
The results show that the amount of social support perceived by pregnant women 
can affect stress and depression scores. Thus, by focusing in the detection of those 
women with low levels of social support within the population attended at the hospital, 
we may be able to identify those women with higher vulnerability for experiencing 
higher levels of stress or depression during pregnancy. 
While being evaluated, many women commented to me their need to learn stress 




stress management activities. The establishment of a stress management program for 
pregnant women at the National Institute of Perinatology would be highly appropriate 
and, along with social support groups, may have an impact on pregnancy outcomes. 
The results of this study can be useful in promoting social change for those 
pregnant women in vulnerable psychosocial situations because they show the importance 
of psychosocial well being during pregnancy and the possible impact of some emotional 
aspects on pregnancy outcomes, by affecting allostatic load.  Pregnancy is a delicate time 
for the mother and the fetus. It is a time where neuroendocrine changes promoted by 
chronic stress or depression have shown to affect immune system regulation (Wadhwa et 
al., 2001) that may lead to pregnancy complications (Coussons-Read, Okun, & Nettles, 
2007) or the metabolic programming of the fetus (Beijers et al., 2010; Brunton et al., 
2010). This is why the uses of education resources promoting healthy lifestyle patterns, 
the establishment of stress management programs during pregnancy, and the promotion 
of social support groups, especially for those single pregnant women and those in scarce 
support conditions, could promote a positive impact in our society. 
Limitations and Future Recommendations 
Limitations 
 As many participants did not complete the MBMD test correctly, many were not 
able to be located by the researcher after delivery, and many others had missing data, the 
required sample to have a power of  0.80 was not achieved and may represent a limitation 
of this study. With a sample of 242 participants, the power of this study was 0.74, 




the development of pregnancy complications, studies on this matter require a large 
sample size, especially for multivariate statistical analyses like logistic regression, in 
which many factors are evaluated at the same time. Perhaps, the sample size of this study 
was not big enough to find statistical differences in the logistic regression analyses. 
Furthermore, poor model fit for logistic regression analyses may not have affected results 
regarding variable interactions, which may also be a limitation of this study. 
 Another limitation of this study was that it included mostly women from low-
income families. Women from low socio-economical status could be exposed to different 
stressors or situations that may affect their emotional well being during pregnancy, 
compared to those from medium or high-income families. This may render these results 
less generalizable. 
 Additionally, this study did not include the measurement of allostatic load 
biomarkers or the evaluation of immune system components. Since it is thought that 
stress and depression may influence pregnancy outcomes through changes in cortisol, 
pregnancy hormones, and cytokine regulation, a relevant part of the pathophysiological 
mechanisms involved were not evaluated by this study. Lastly, the interaction between 
pathologies present in 136 of participants with pregnancy outcomes was not evaluated in 
the current study, which may also represent a limitation of the study. 
Future Recommendations 
 Future research projects regarding the effects of stress and depression on the 
development of pregnancy complications should include the evaluation of allostatic load 




biological pathways are involved in increasing risk for preterm birth, low-weight for 
gestational age or other poor perinatal outcomes. Also, the relationship between stress 
and depression with gestational hypertension and gestational diabetes could be evaluated 
in follow-up studies. Future recommendations for research would also include a bigger 
sample size for logistic regression in order to have adequate statistical power.  
The finding that depression may be associated with higher newborn weight is interesting 
and it would be appropriate to do further research on this matter to explore if this could 
be related to increased cortisol levels or to a higher incidence of gestational diabetes in 
depressed women. However, this finding may also be a statistical artifact, given its 
counterintuitive nature.  
 While collecting the data, the researcher noticed many potential research gaps that 
could be explored in future studies, such as the relationship between psychosocial factors 
and the development of gestational hypertension and gestational diabetes.  
Conclusion 
Overall, the findings lend partial support to the notion that psychosocial factors 
can increase the risk for pregnancy complications. Even though the mechanisms by 
which emotional factors can affect pregnancy outcomes are not fully known, several 
studies indicate possible contributors to neuroendocrine changes that may affect the 
delicate immunorregulatory processes involved during pregnancy. Further studies are 





The results of this study indicate that single maternal socioeconomical status, low 
levels of social support, low family income, the number of pregnancies, high stress 
scores, and high depression scores are elements contributing, directly or indirectly, to the 
development of pregnancy complications or poor pregnancy outcomes. 
Importantly, many of these factors are potentially modifiable. This means that we 
could have an impact on some psychosocial factors that may be contributing to 
pregnancy morbidity by creating social support groups for women in low social support 
environments, and stress management programs for those women with high levels of 
stress. Unfortunately, many psychosocial factors that may contribute to poor pregnancy 
outcomes are also related to low socioeconomical status, which is a difficult factor to 
modify in the short term. This study’s results aim to promote awareness regarding the 
psychosocial conditions of the Mexican pregnant woman that may be contributing to poor 
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Appendix A: Informed Consent  
Informed Consent for the Effects of Stress/Anxiety, Depression and Emotional 
Lability on the Development of Pregnancy Complications Study (English) 
CONSENT FORM 
You are invited to take part in a research study that will evaluate the effects of 
stress/anxiety, depression and emotional lability on the development of pregnancy 
complications. The researcher is inviting pregnant women who are 18 to 42 years old, in 
any trimester of pregnancy, who don’t have chronic hypertension, and who will be 
receiving prenatal consultations at the National Institute of Perinatology to be in the 
study. This form is part of a process called “informed consent” to allow you to 
understand this study before deciding whether to take part.  
This study is being conducted by a researcher named Dr. Estibalitz Laresgoiti, MD, who 
is a PhD student at Walden University. 
Background information 
The purpose of this study is to evaluate if stress, depression and/or emotional lability 
during pregnancy can be associated to the development of preeclampsia, abruptio 
placentae, preterm birth and low birthweight for gestational age babies. This study 
will also appraise if the amount of perceived social support may influence the levels 
of stress, anxiety, depression and emotional lability. This study will also assess if 
women with higher levels of stress or emotional lability deliver babies with lower 
birthweight.  




who receive prenatal healthcare at the National Institute of Perinatology, who accept to 
participate by signing the Statement of Consent will be included in the study.  
Procedures 
If you agree to be in this study, you will be asked to: complete the administration of two 
written tests. The first one will evaluate the level of stress, anxiety or depression that you 
may be experiencing during pregnancy. The second test will help the researcher know the 
amount of perceived social support that you have during this pregnancy. Information 
regarding your age, your socioeconomical status and your social status will also be 
needed. The participants will dedicate approximately 35 minutes of their time to answer 
the written tests. You will then be followed until pregnancy termination when the 
researcher will record if you developed pregnancy complications and your pre pregnancy 
and post-delivery weight in your medical record. The researcher will not contact you at 
this time because the follow up data will be retrieved from the medical record. Your 
baby´s birthweight and Apgar will also be obtained as well from medical records.  
This study will not evaluate any treatments. In this study, measurements of stress, 
anxiety, depression, and emotional lability will be performed during pregnancy. After 
delivery, the development of pregnancy complications and birth conditions of your baby 
will be recorded. Afterwards, the researcher will evaluate if the levels of stress, anxiety 
depression or emotional lability can be correlated with the development of pregnancy 
complications.  
Voluntary Nature of the Study 




choose to be in the study. No one at the National Institute of Perinatology will treat you 
differently if you decide not to be in the study. If you decide to join the study now, you 
can still change your mind later. You may stop at any time.  
If you agree to participate in this research study, you will be asked to sign the Statement 
of Consent located below this Informed Consent Form. By accepting to participate, you 
agree to answer the Millon Behavioral Medicine Diagnostic Test, which will help us 
measure the parameters previously mentioned, and the Social Support Questionnaire that 
will evaluate the level of perceived social support by the participant during pregnancy.  
The participant will commit to stay in touch with the researchers so they can follow her 
pregnancy until delivery, which may take place at the National Institute of Perinatology, 
or, if not possible, at another hospital. 
Risks and Benefits of Being in the Study: 
Being in this type of study may involve some risk of the minor discomforts that can be 
encountered in daily life, such as becoming upset due to test administration. However, 
there are no known risks for the tests that will be used in this study. Being in this study 
would not pose risk to your safety or wellbeing.   
If you decide to participate in this study, the benefits for you and your baby will not be 
directly reflected in the short term. The information that will be obtained in this study 
may allow us to implement new parameters in health care attention for the pregnant 
woman, and establish outlines for the prevention of pregnancy complications. In this 
study, we pretend to evaluate the psychosocial factors that can be modified in order to 






The participation in this study will have no monetary cost for any participant. Neither the 
participant will receive any type of compensation for her participation in this study. Your 
participation in the study is voluntary and you are free to withdraw at any time. Your 
decision to participate in this study will not affect your relationship with the National 
Institute of Perinatology neither the quality of the health care services that you receive as 
a patient of this Institute. 
You may ask the researchers for a report of the results from the Millon Behavioral 
Medicine diagnostic test and the Social Support Questionnaire after you deliver your 
baby, and this will have no cost for you.  
Privacy 
The records of this study will be kept confidential. The demographic, psychosocial and 
health related information will be kept private and will only be revised by the researcher.  
During data analysis, your information will not be identified by your name; you data will 
be linked to your medical record number at the National Institute of Perinatology. Only 
the researcher participating in this project will be able to link the tests results with you. 
Research records and databases will be saved in password-protected files. In any sort of 
report that might be published, I will not include any information that will make it 
possible to identify a participant. The data will only be used for research matters and will 
not be used other persons not related to this study. Data will be kept for a period of at 





Contacts and Questions 
You may ask any questions you have now. Or if you have questions later, you may 
contact the researcher. If you have any doubts regarding the informed consent process or 
your rights as a research study participant please contact de Human Research Studies 
Committee of the National Institute of Perinatology. Walden University’s approval 
number for this study is _______and it expires on ___________ 
This project has been approved and is supervised by the Bioethics and Research 
Committee of this the National Institute of Perinatology. This Committee is formed by a 
group of experts that revises meticulously the research projects and the possible risks for 
the participants of the study  
The researcher will give you a copy of this form to keep 
Statement of Consent 
I have read the above information and I feel I understand the study well enough to make a 
decision about my involvement.  
By signing below I confirm that I have read the informed consent form for the 
participation in this study, which has been given to me. My participation in this project is 
entirely voluntary and I know am free to refuse to participate or finish my participation at 
any moment, without this affecting the health care services I receive now, or will receive 
in the future.  I consent to participate in this study because I have had the opportunity to 




enough information regarding my participation in this research study. I understand that I 
am agreeing to the terms described above. 
 
Printed Name of Participant    _____________________________ 
Date of Consent     ______________________________ 
Participant’s Signature    ______________________________ 






Informed Consent for the Effects of Stress/Anxiety, Depression and Emotional 
Lability on the Development of Pregnancy Complications Study (Spanish) 
FORMA DE CONSENTIMIENTO INFORMADO 
Se le invita a formar parte de un estudio de investigación que evaluará los efectos del 
estrés/ansiedad, depresión y labilidad emocional en el desarrollo de complicaciones del 
embarazo.  El investigador esta invitando a las mujeres embarazadas, de 18 a 42 años de 
edad, en cualquier trimestre del embarazo,  que no tengan hipertensión crónica previa al 
embarazo y que reciban atención perinatal en el Instituto Nacional de Perinatología. Esta 
forma es parte del proceso llamado “consentimiento informado” que permitirá a usted 
entender este estudio antes de decidir si quiere participar. 
Este estudio será dirigido por la investigadora llamada Dra. Estibalitz Laresgoiti, quien es 
una estudiante de doctorado en Walden University. 
Antecedentes e Información General 
El objetivo de este estudio es saber si  el estrés, la labilidad emocional y la depresión 
durante la gestación pueden estar asociados al desarrollo de preeclampsia, 
desprendimiento prematuro de placenta normo inserta, parto pretérmino y con el 
estado de su bebé al nacer. El estudio también evaluará si el apoyo social percibido 
por la paciente durante el embarazo puede afectar los niveles de estrés, ansiedad o 
depresión de la madre. Este estudio evaluará también si los pacientes con mayores de 
niveles de estrés o labilidad emocional tienen bebés con menor peso al nacimiento. 
Procedimientos 




primera prueba nos ayudará a evaluar el nivel de estrés, ansiedad o depresión que pudiera 
usted estar presentando durante su embarazo. La otra prueba será un cuestionario que nos 
ayudará a conocer el apoyo social con el que usted cuenta durante su embarazo. También 
se solicitará a usted información sobre la edad que tiene durante este embarazo y  su 
estado civil. Las participantes dedicarán aproximadamente 35 minutos de su tiempo para 
responder las pruebas escritas. Será usted posteriormente monitoreada por los 
investigadores hasta el fin de su embarazo para evaluar si usted presentó alguna 
complicación durante el mismo y cual fue el Apgar de su bebé al nacimiento. Se 
registrará también el  peso de su bebé al nacimiento y el peso de usted al iniciar y 
terminar su embarazo. El investigador no lo contactará al final de su embarazo porque el 
resto de los datos necesarios para el estudio se obtendrán de su expediente clínico. 
El estudio no propone evaluar ningún tipo de tratamiento,. Lo que se hará será medir los 
niveles de estrés, ansiedad y depresión durante el embarazo y se seguirá a la mujer hasta 
el final del embarazo. Después del nacimiento de su bebe se revisara en su expediente 
clínico si usted desarrollo alguna complicaciones del embarazo y se  registrarán las 
condiciones de nacimiento de su bebé. Posteriormente se evaluará si los niveles de estrés, 
ansiedad o depresión en el embarazo se pueden estar relacionados con el desarrollo de 
ciertas complicaciones del embarazo.  
 
Naturaleza Voluntaria de este Estudio 
Este estudio es voluntario. Todos respetaran su decisión sobre si participar o no en el 




decide no participar en este estudio. Si decide ser arte del estudio ahora, puede cambiar 
de opinión posteriormente. Puede acabar su participación en cualquier momento. 
Si está de acuerdo en participar en este estudio de investigación se le pedirá que firme la 
declaración de consentimiento informado localizada al final de esta carta. Al aceptar 
participar en el estudio, usted acepta contestar la prueba Millon de Diagnóstico de 
Comportamiento para el Campo Médico, que nos ayudará a medir los parámetros antes 
mencionados, y el Cuestionario de Apoyo Social de Sarason, que busca evaluar el nivel 
de apoyo social percibido por la paciente durante el embarazo. La paciente se 
comprometerá a mantenerse en contacto con los investigadores para que estos puedan 
seguir su embarazo hasta su final, ya sea en el INPer, o en otro hospital, en caso de que el 
nacimiento no haya sido en esta Institución. 
Riesgos y Beneficios de Participar en este Estudio 
El participar en este estudio puede involucrar algún riesgo de incomodidades menores 
encontradas en el su vida diaria, como por ejemplo, estar incomoda con la administración 
de las pruebas.. Sin embargo, no hay riesgos conocidos para las pruebas que se usarán en 
este estudio. El participar en este estudio no pone en riesgo su seguridad y bienestar. Las 
pacientes solo tendrán que dedicar aproximadamente 25 minutos para contestar las 
pruebas escritas. 
Si usted decide ingresar al estudio, el beneficio para usted y su hijo(a) no será directo. La 
información que se obtenga podría permitir en un futuro implementar nuevas medidas de 
atención y nuevos esquemas de prevención de complicaciones del embarazo. En este 




mejorar el pronóstico materno-neonatal. 
Pagos o Remuneraciones 
No hay ningún costo para usted por participar en este estudio. Tampoco los participantes 
de este estudio recibirán algún tipo de compensación económica o de otro tipo por 
participar en el estudio. Su participación en este estudio es totalmente voluntaria y es 
usted libre de terminar su participación en cualquier momento. Su dedicación  de 
participar en este estudio no afectará su relación con el Instituto Nacional de 
Perinatología ni la calidad de los servicio de salud que recibe como paciente en este 
Instituto. 
Usted podrá solicitar un reporte de los estudios de los resultados de la prueba Millon y 
del Cuestionario de Apoyo Social de Sarason a los investigadores al término de su 
embarazo, sin generarse ningún costo por ello. 
Privacidad y Confidencialidad 
La información médica obtenida durante este proyecto se mantendrá como confidencial. 
La información demográfica, psicosocial y relacionada a la salud será siempre 
confidencial y únicamente será revisada por el investigador de este estudio. Durante el 
análisis de los datos, su información no será identificada con su nombre; sus datos estarán 
ligados a su número de expediente clínico del Instituto Nacional de Perinatología y  solo 
el investigador principal del estudio podrá relacionar sus resultados con usted. Las bases 
de datos que contienen la información de las participantes se mantendrá en archivos 
protegidos con contraseña. Cualquier tipo de reporte que sea publicado sobre este estudio 




datos que se obtengan de este estudio serán utilizados con fines de investigación y no 
serán usados por personas ajenas a este estudio.  
Contactos y Preguntas 
Podrá hacer preguntas en cualquier momento acerca de este estudio. En caso de alguna 
duda o si requiere de mayor información se debe comunicar con la encargada del estudio. 
 Si tiene cualquier duda sobre el proceso de consentimiento informado o sus derechos 
como un sujeto en investigación deberá ponerse en contacto con el Comité de 
Investigación para estudios en Humanos en el Instituto Nacional de Perinatología. El 
número de aprobación de Walden para este estudio es ____________y expira el 
_________________. 
La realización de este estudio ha sido aprobada y supervisada por el Comité de 
Investigación y de Bioética de este hospital, quienes son un grupo de expertos que 
revisan detalladamente los protocolos de estudio y el riesgo para los sujetos de estudio.  
El  investigador le entregará una copia de esta forma para que usted la conserve. 
Declaración de Consentimiento 
He leído la hoja de consentimiento informado que se me ha entregado y entiendo el 
proyecto lo suficiente como para tomar una decisión sobre mi participación. 
Al firmar abajo confirmo que he leído la forma de consentimiento que se me ha otorgado 
para la participación en este estudio. Mi participación  en el proyecto es enteramente 
voluntaria y soy libre de rehusar a tomar parte o a abandonar en cualquier momento, sin 




Consiento en participar en este proyecto, he tenido la oportunidad de plantear mis dudas, 
temores, expectativas respecto al estudio. Se me ha proporcionado información suficiente 
acerca de todo lo referente al estudio, han respondido todas mis preguntas. Entiendo que 
estoy de acuerdo con los términos descritos anteriormente.  
 
Nombre de la Participante     ________________________ 
Fecha de Consentimiento     ________________________ 
Firma de la Participante     ________________________ 














Authorization to Use or Disclose PHI for Research Purposes (English) 
The top portion of this form (above the dotted line) should be completed by the 
researcher.  A copy of the form should be given to the research participant for his/her 
personal records. 




Discloser of Information: National Institute of Perinatology Health Records 
Recipient of Information: Estibalitz Laresgoiti Servitje 
Means of disclosing information (i.e., verbal, written, etc.): Information will be 
uploaded to a database for statistical analysis. Only the researcher will be able to  link the 
information obtained from medical records with the participant. The participant’s identity 
will be concealed. 
Information to be disclosed:     
Medical data 
Reason for the Release:  This information is being released/obtained for the purpose of 
evaluating the role of stress,/anxiety, depression, and emotional lability on the 
development of pregnancy complications. The data that will be obtained from medical 
records will be: pregnancy outcomes (development of preeclampsia, perterm labor and 







Authorization Provided by Research Participant:   
I understand that this authorization permits the release of information between the two 
parties named above.   
I understand that I have the right to refuse to sign this release form. 
I understand that upon release, this information will be kept confidential; my identity will 
be concealed and data will not be re-disclosed outside of the specified individuals or 
agencies.  
I understand a photocopy of this release will be as effective as the original. 
I understand this authorization will be in effect for 12 months from the date signed unless 
cancelled by me in writing.  Upon receipt of the written cancellation, this release will be 
void.  
______________________________________________________________________ 
Signature                                                                                                             Date 
______________________________________________________________________ 







Authorization to Use or Disclose PHI for Research Purposes (Spanish) 
Autorización para Liberar/Usar Información Privada  
del Expediente Clínico con Fines de Investigación  
La porción superior de esta forma (por arriba de la línea punteada) deberá ser llenada por 
el investigador. Una copia de esta forma deberá ser entregada a la participante.  




Persona que libera la información: Expediente Clínico del Instituto Nacional de 
Perinatología 
Persona que recibe la información: Estibalitz Laresgoiti Servitje 
Manera de liberar la información: La información obtenida del expediente clínico y de 
las pruebas SSQ y MBMD se incorporará a una base de datos para hacer análisis 
estadístico. Sólo la investigadora podrá enlazar la información obtenida del expediente 
clínico y las pruebas  con los datos de la participante.   
Información que será obtenida:    Información médica 
Razón para liberación de información: Esta información será liberada/obtenida con el 
fin de evaluar el efecto del estrés/ansiedad, depresión y labilidad emocional en el 
desarrollo de complicaciones del embarazo. La información que será obtenida del 
expediente clínico será la siguiente: desarrollo de complicaciones del embarazo 




el desarrollo de infecciones durante el embarazo, el Apgar del recién nacido y el peso del 
bebe al nacimiento. 
________________________________________________________________________ 
Autorización Dada por la Participante del Estudio de Investigación:  
Entiendo que esta autorización permite la liberación de la información entre las dos 
personas anteriormente mencionadas.  
Entiendo que tengo el derecho de negarme a firmar esta carta de liberación.  
Entiendo que al liberarse esta información, esta será mantenida como confidencial y mi 
identidad se mantendrá oculta y mis datos no serán revelados a nadie fuera de este 
proyecto de investigación.   
Entiendo que una copia de esta carta de liberación será igual de efectiva que la original. 
Entiendo que esta autorización tendrá efecto durante los doce meses siguientes a partir de 
la fecha abajo mencionada a menos de que sea cancelada por mi a través de una petición 
escrita. En cuanto se reciba una cancelación escrita, esta carta de liberación se invalidará.  
______________________________________________________________________ 
Firma                                                                                                              Fecha   
______________________________________________________________________ 














Appendix D: Demographic Questionnaire 
Demographic Questionnaire (English) 
The completion of this demographic questionnaire is relevant for 
determining the influence of several of factors on the results of this study.  All of 
these records will remain confidential.  
Age:  _____ 
Trimester at which the evaluation is taking place:   
First: ______ 
Second: _______  
Third: ________ 
Gestational week at which evaluation is taking place: _________ 
Social status: 
Married ____  










Demographic Questionnaire (Spanish) 
El llenado de este cuestionario es muy importante para determinar la influencia de varios 
factores sobre los resultados del estudio. Todos los datos serán confidenciales.  
Edad  _____ 




Edad gestacional en la que se esta evaluando: _________ 
Estado civil: 











Appendix E: Permission to Use Social Support Questionnaire 
The Sarason Questionnaires are in the public domain and may be obtained from 
the University of Washington, Department of Psychology web site: 
http://www.psych.uw.edu/psych.php#p=161 
The Sarason Social Support Questionnaire and the Social Support Questionnaire 
(short form) have been developed by Irwin and Barbara Sarason and their associates. 
They are in PDF format (Adobe Reader required) and include the original articles that 
describe them. 
Permission is granted to researchers to use these instruments. However, Dr. 
Sarason would appreciate information about the findings of studies in which they are 
used. Anyhow, I asked Dr. Sarason for permission to use the SSQ6. Below is his 
response: 
From: Irwin Sarason  
Subject: Re: Permission to use the short version of the Social Support Questionnaire 
Date: 31 de mayo de 2012 14:48:14 PDT 
To: Estibalitz Laresgoiti  
Respond to: Irwin Sarason  
 
You have my permission. There is some useful information at 
http://web.psych.washington.edu/research/sarason/ 
Irwin Sarason 
Department of Psychology 





On May 11, 2012, at 8:35 PM, Estibalitz Laresgoiti wrote: 
 
Dear Dr. Sarason, 
My name is Estibalitz Laresgoiti and I am a PhD student in health psychology at 
Walden University. I have a medical doctorate degree, a master's in science degree in 
immunology, and a master's degree in neurosciences. My background is in pregnancy 
immunology and in psychoneuroimmunology. I am interested in pursuing my dissertation 
in the area of stress and the development of pregnancy complications. I have been 
searching for an instrument that would explore perception of social support in pregnant 
women. I was fascinated when I found the short version of your Social Support 
Questionnaire in the journal of Social and Personal Relationships. This journal does have 
a copy of the short version of the Social Support Questionnaire, but I am not sure if the 
questionnaire is available for public use. I want to ask for your permission to use it in my 
dissertation study. I would truly appreciate your assistance on this matter, and any 
direction you might offer. 
Please feel free to contact me  
Thank you in advance for your help 
Sincerely, 
 
Estibalitz Laresgoiti Servitje 





Appendix F: Short Version of the Social Support Questionnaire 
 
Sarason, I.G., Sarason, B.R.., Shearin, E.N., & Pierce, G.R. (1987). A brief measure of 
social support: Practical and Theoretical implications. Journal of Social and Personal 
Relationships, 4, 497-510.  
Social Support Questionnaire 6 (SSQ6) (English) 
Instructions:  
The following questions ask about people in your life who provide you with help or 
support. Each question has two parts. For the first part, list all the people you know, 
excluding yourself, whom you can count on for help or support in the manner described. 
Give the person’s initials and their relationship to you (see example). Do not list more 
than one person next to each of the numbers beneath the question.  
For the second part, circle how satisfied you are with the overall support you have.  
If you have no support for a question, check the words “No one,” but still rate your level 
of satisfaction. Do not list more than nine persons per question.  
Please answer all questions as best you can. All your answers will be kept confidential.  
Example:  
Who do you know whom you can trust with information that could get you in 
trouble? 
 
No one   1) T.N. (brother)  4) T.N. (father)  7) 
  2) L.M. (friend)  5) L.M. (employer)  8) 








satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
1. Whom can you really count on to be dependable when you need help?  
No one  1)   4)   7) 
  2)   5)   8) 
  3)   6)   9) 
 
2. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
3.  Whom can you really count on to help you feel more relaxed when you are 
under pressure or tense? 
No one 1)   4)   7) 
  2)   5)   8) 
  3)   6)   9) 
 
4. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
5.  Who accepts you totally, including both your worst and your best points? 
No one 1)   4)   7) 
  2)   5)   8) 
  3)   6)   9) 
 
6. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
7. Who can you really count on to care about you, regardless of what is 
happening to you? 
 
No one 1)   4)   7) 
  2)   5)   8) 




8. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
9.  Whom can you really count on to help you feel better when you are feeling 
generally down-in-the-dumps? 
No one 1)   4)   7) 
  2)   5)   8) 
  3)   6)   9) 
 
10. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
11.  Who can you count on to console you when you are very upset? 
 
No one 1)   4)   7) 
  2)   5)   8) 
  3)   6)   9) 
 
12. How satisfied? 
 
6) very  5) fairly  4) a little 3) a little 2) fairly 1) very  
satisfied  satisfied satisfied dissatisfied dissatisfied dissatisfied 
 
To score SSQ6:  
1. Add total number of people for all 6 odd-numbered items. (Max. is 54). Divide by 6 
for per item score. This gives you SSQ Number Score, or SSQN.  
2. Add total satisfaction scores for all 6 even-numbered items. (Maximum is 36). Divide 
by 6 for per item score. This gives you SSQ Satisfaction score or SSQS.  
3. You can add up the SSQN score and the SSQS score to obtain the total social support 




Cuestionario de Apoyo Social 6 (SSQ6) (Español) 
Instrucciones:  
Las siguientes preguntas evalúan las personas en su vida que le dan a usted ayuda o 
apoyo. Cada pregunta tiene dos partes. Para la primera parte, enliste todas las personas 
que conoce, excluyéndose a usted, en las que usted puede contar para ayuda o apoyo en la 
manera descrita. Escriba las iniciales de esta persona y la relación con usted (vea el 
ejemplo). No enliste más de una persona junto a los números debajo de la pregunta y no 
enliste más de nueve personas por pregunta. Para la segunda parte, circule que tan 
satisfecha se siente con el apoyo que tiene.. Si no tiene apoyo en alguna de las preguntas, 
marque la palabra “Nadie”, pero de todas formas marque su nivel de satisfacción.  
Por favor, conteste todas las preguntas lo mejor que pueda. Todas sus respuestas serán 
confidenciales.   
Ejemplo:  
¿A quien conoce usted que pueda confiar con información que podría ponerla en 
problemas?  
 
Nadie  1) T.N. (hermano)  4) T.N. (padre)  7) 
  2) L.M. (amigo)  5) L.M. (jefe)   8) 
  3) R.S. (amiga)  6)    9) 
 
¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
 
1. Con quién puede usted realmente contar para apoyarla cuando necesita 
ayuda?  
Nadie 1)    4)    7) 




  3)    6)    9) 
 
2. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
3. Con quién puede usted realmente contar para sentirse más relajada cuando 
está bajo presión o está tensa? 
Nadie 1)    4)    7) 
  2)    5)    8) 
  3)    6)    9) 
 
4. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
5. ¿Quién la acepta totalmente como es, incluyendo sus mejores y sus peores 
puntos?  
Nadie 1)    4)    7) 
  2)    5)    8) 
  3)    6)    9) 
 
6. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
7. ¿En quién puede usted realmente contar para cuidar de usted, sin importar 
lo que le esté pasando a usted?  
 
Nadie 1)    4)    7) 
  2)    5)    8) 
  3)    6)    9) 
 
8. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 





9.  ¿Con quién puede usted realmente contar para ayudarla a sentir mejor 
cuando se siente deprimido y abatido?  
Nadie 1)    4)    7) 
  2)    5)    8) 
  3)    6)    9) 
 
10. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
 
11.  ¿Con quién puede usted contar para consolarla cuando se sienta molesto o 
perturbado?  
 
Nadie 1)    4)    7) 
  2)    5)    8) 
  3)    6)    9) 
 
12. ¿Qué tan satisfecha está usted con este apoyo? 
 
6) muy  5) algo  4) poco 3) poco 2) algo  1) muy 
satisfecha  satisfecha satisfecha insatisfecha insatisfecha insatisfecha 
 
Para calificar el  SSQ6:  
1. Sumar el número total de las personas por las 6 preguntas nones que valoran la 
red de apoyo social. El máximo es 54. Dividir entre 6 para obtener la calificación  
la red de apoyo social.  
2. Sumar la calificación de las preguntas pares, que valoran el grado con el cual la 
persona está satisfecha con el grado de apoyo social recibido. El máximo es 36.  





3. Sumar la calificación de la red de apoyo social, más la calificación de la 
satisfacción de apoyo social para obtener la calificación total de apoyo social. La 





Appendix G: Permission to Use MBMD 
 The Millon Behavioral Medicine Diagnostic (MBMD) Test is distributed by 
Pearson Assessments. I am an authorized administrator of the MBMD test. The Spanish 
Q Local / MBMD Answer Sheets will be bought through Pearson’s web site, and the tests 





Appendix H: IRB Materials Approval 
Walden’s Univeristy Institutional Review Board (IRB) approved application for the study 
entitled, "Effect of Stress/Anxiety, Depression and Emotional Lability on the 
Development of Pregnancy Complications."  




Appendix I: Tables and Additional Information 
As shown in Table I1, single pregnancies were the most common, accounting for 
95.5% of pregnancies. Eleven participants were pregnant with twins and only one 
participant had triplets. 
Table I1 
Number of Babies in Uterus 
 Frequency Percent 
 
1 231 95.5 
2 10 4.1 
3 1 0.4 
Total 242 100.0 
 
One baby died in uterus before pregnancy termination due to unknown causes. No 
placental or maternal causes were identified. The remaining 99.5% were born alive (see 
Table I2). 
Table I2  
Alive or Deceased Newborns 
 Frequency Percent 
 
Alive 241 99.5 
Deceased 1 0.5 
Total 242 100.0 
 
Mean gestational age at delivery was 38.19 weeks. The mean newborn height was 







Newborn Weight at Delivery 





Valid 242 242 
Missing 0 0 
Mean 38.19 2904.44 
Median 38.30 2904.50 
Mode 38.3 2790a 
SD 1.58 488.67 
Minimum 31.5 1564 
Maximum 41.6 4236 
a. Multiple modes exist. The smallest value is shown 
 
Of the 242 participants, 254 babies were born. 56.2% of babies were female and 
43.8% were male. One baby had dysmorphic external genitalia and was categorized as 
female after genetic evaluation.  
Table I4 
Newborn’s Sex 
 Frequency Percent 
 
Female 143 56.2 
Male 111 43.8 
Total 254 100.0 
 
Most babies (93.8%) were born healthy. However, ten had minor malformations, 
one was born with Down Syndrome, one had gastroschisis, one had cystic hygroma, one 





Table I5  
Newborn Illness 
 Frequency Percent 
 
None 227 93.8 
Minor malformations 10 4.1 
Trisomy 21 1 0.4 
Gastroschisis 1 0.4 
Cystic Hygroma 1 0.4 
Microcephaly 1 0.4 
Cleft lip and palate 1 0.4 
Total 242 100.0 
 
Mean gestational age at delivery was 38.19 weeks. The mean newborn height was 
48.7 cm and the mean weight of newborns was 2904 grams. The mean Apgar score at 
minute 1 was 7.93 and the mean Apgar score ar 5 minutes was 8.92. Mean Silverman 
Anderson scoring for babies was 1.6 (see Table I6). 
Table I6 
Newborn Conditions at Delivery 













Valid 242 242 242 242 242 242 
Missing 0 0 0 0 0 0 
Mean 38.19 48.70 2904.44 7.93 8.92 1.60 
Median 38.30 49.00 2904.50 8.00 9.00 2.00 
Mode 38.3 50.0 2790a 8 9 2 
SD 1.58 2.64 488.67 0.92 0.67 .64 
Minimum 31.5 36.0 1564 0 0 0 
Maximum 41.6 54.0 4236 9 10 5 






The mean number of maternal infections during pregnancy was 0.91. Statistics are 
shown in Table I7. Urinary tract infections, respiratory airway infections, gastrointestinal 
infections and cervicovaginitis were considered. 
Table I7 
Number of Maternal Infections During Pregnancy 












Social Support Scores 






Mean 15,88 32.32 48.20 
Median 14,00 35.00 48.00 
SD 9,08 6.595 12.07 
Minimum 0 6 13 







Estibalitz Laresgoiti Servitje 
Curriculum Vitae 
 
Date of birth: 26 de Septiembre de 1972 
Place of birth Distrito Federal, Mexico 
Profession and specialty: Physician with postgraduate studies in the 




Candidate for Doctor of Philosophy      2009 - Present 
Walden University, Minneapolis, Minnesota. 
GPA 3.8 
Dissertation: The Effects of Stress, Depression  
and Emotional Lability on the Development  
of Pregnancy Complications. 
 
Master in Neurosciences             2004-2005 
Universitat Oberta de Catalunya,  
Neurosciences and Mental Health Institute.  
Barcelona, Spain. 
Thesis: Psychoneuroimmunology. Multidirectional Communication.  
 
Master of Sciences in Immunology            1997-2000 
National School of Biological Sciences.  
Instituto Politécnico Nacional. 
Distrito Federal, Mexico 
Mean score: 9.7 
Thesis: Analysis of the Cytokine Pattern and other Proteins  
Secreted by J-774 Cells Infected with Bacteria of the Tuberculosis Complex. 
 
Medical Doctorate              1991-1996 
Anáhuac University, School of Medicine.  
Huixquilucan, State of Mexico 
Universidad Nacional Autónoma de Mexico (UNAM) 
Mean score: 9.74 
 
Primary, Secondary and High School Studies          1977-1985 
Instituto Mexicano Regina             1986-1991 





First year of Secondary Studies            1985-1986 
Pensionnat International de La Chassotte 
Fribourg, Switzerland.. 
 
LICENSURE AND CERTIFICATIONS 
 
- Medical Doctorate Professional License: DGP, SEP 2619183. Mexico. 
- Master of Sciences in Immunology Professional License: DGP, SEP: 5296108. Mexico 
- National Council of General Practitioners Certification (CONAMEGE), 2011-2016 
Registry 11/01/09-1437-10912. Mexico. 
- Stress Management Technique Instructor Certification, 2011. American Holistic Nurses 




Clinical Practice in Immunology      2011 – Present 
American British Cowdray Medical Center. Mexico. 
 
Professor of Physiopathology and Propaedeutic    2011 – Present 
School of Medicine. Panamerican University. 
Distrito Federal, Mexico. 
Molecular bases and triggers of autoimmunity. Physiopathology of small, medium 
and large vessel vasculitis. Physiopathology of dermatomyositis, polymyositis, 
antiphospholipid syndrome, scleroderma, systemic lupus erythematosus, 
spondyloarthropaties, Sjögren syndrome and rheumatoid arthritis.  
 
Professor of Immunology             2010-2011 
School of Medicine. Panamerican University. 
Distrito Federal, Mexico 
Components of innate and adaptive immunity. Major histocompatibility complex 
molecules. Antigen processing and presenting in MHC molecules. Immune 
response induction. Lymphocyte intracellular signaling. Immune system 
regulation. Hypersensitivity mechanisms. Molecular and genetic basis and 
triggers of autoimmunity. Immune responses to bacteria, virus, parasites, fungi 
and prions. Primary and secondary immunodeficiencies. 
 
 
Professor of Clinical Immunology          2003 – 2009 
School of Medicine. Anáhuac University. 
Huixquilucan, Estado de Mexico 
Active immunization, vaccines and adjuvants. Reproductive immunology. Blood 
groups and ABO incompatibility reactions. Rh Isoimmunization. Hypersensitivity 




responses to bacteria, virus, parasites, fungi and prions. Primary and secondary 
immunodeficiencies. Solid organ transplant immunology. 
 
Professor of Basic Immunology            2002-2010 
School of Medicine. Anáhuac University. 
Huixquilucan, Estado de Mexico 
Immune system ontogeny. Primary and secondary lymphoid organs. Components 
of innate and adaptive immune system. Cytokines. Major histocompatibility 
complex molecules. Dendritic cells. Antigen processing and presentation T and B 
lymphocytes’ activation. Immune system regulation. Hypersensitivity 
mechanisms. Autoimmunity.  
 
Chemistry Teacher              2001-2002 
School of Medicine. Anáhuac University. 
Huixquilucan, Estado de Mexico 
Inorganic chemistry. Atom. Electron. Electronegativity. Types of bonds, Water 
and solubility. Acids and bases. Dissociation coefficients. pH and buffers. 
Acid/base disequilibrium. Solutions and colloids. Mole, molarity, molality and 
normality. Equivalent. Osmosis. Osmotic pressure. Colloid osmotic pressure. 
Alkanes, alkenes, alkynes, alcohols, esters, ether, ketones and amines  
 
Biochemistry Teacher              1998-1999 
School of Medicine. Anáhuac University. 
Huixquilucan, Estado de Mexico 
pH and acid/base disequilibrium. Proteins. Primary, secondary, tertiary and 
quaternary structure of proteins. Enzymes. Carbohydrates. Carbohydrate 
metabolism. Glycogenesis. Glycogenolysis. Glycolysis. Krebs cycle. Oxidative 




Collaboration in projects with the Psychoneuroimmunology Group……….2012-Present 
at the National Institute of Perinatology 
 
Collaboration as a writer for the website www.infogen.org.mx                   2011 - Present 
Web site dedicated to the diffusion of pregnancy knowledge and birth defects  
prevention information.  
 
Collaboration in projects with Dr. David Olson’s group.               2010 – Present 
Dr. Olson is the Director of the Center for Perinatal Research.  
University of Alberta. Edmonton, Canada.  
 
Collaboration in the project:                  1995-1996 




of S.aureus and coagulase negative Staphylococcus  resistance in 
 nosocomial infections in newborn care units” during research social service  




ARTICLES PUBLISHED IN PEER-REVIEWED JOURNALS 
 
Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of 
preeclampsia. J Leukoc Biol. 2013. In press 
 
Gómez-López N, Laresgoiti-Servitje E. T regulatory cells: regulating both therm and 
preterm labor? Immunol Cell Biol. 2012;90(10):919-920 
 
Laresgoiti-Servitje E, Gomez-Lopez N. (2012). The pathophysiology of preeclampsia 
involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-
mediated mechanisms. Biol Reprod. 2012,87(2):36-42 
 
Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the 
origins of pre-eclampsia. Hum Reprod Update. 2010;16(5):510-24. 
 
Gomez-Lopez N, Laresgoiti-Servitje E, Olson DM, Estrada-Gutierrez G, Vadillo-Ortega 
F. The role of chemokines in term and premature rupture of the fetal membranes: a 
review. Biol Reprod. 2010;82(5):809-14. Epub 2010/01/22. 
 
CONGRESS ABSTRACTS PUBLISHED IN PEER-REVIEWED JOURNALS 
 
Laresgoiti-Servitje, E, Méndez-Aragón P, Serafín López J, Estrada Parra S, Estrada-
García I. Análisis del patrón de citocinas de células J-774 infectadas con bacterias del 
complejo tuberculosis. Rev Latinoam Micriobiol. 2000; 42(Supl):397 MX ISSN 0034-
9771 
 
ARTICLES PUBLISHED IN WEB SITES 
 
Pregnancy and the Immune System  www.infogen.org.mx 
 
The Effects of Stress on Pregnant Women www.infogen.org.mx 
 









ORAL AND PROFESSIONAL PRESENTATIONS 
 
Preeclampsia Immunology: From its Origins to its Pathophysiology 




Immunodeficiencies and their Association with Cancer,            November, 2012 
Allergy and Autoimmunity 
Medical Association Seminars  
American British Cowdray Medical Center, Mexico. 
 
Stress and the Psyhconeuroimmunology of Cancer           July, 2012 
Medical Association Seminars  
American British Cowdray Medical Center, Mexico. 
 
The Effects of Stress on Your Immune System .        April, 2012 
Radio interview with Marthe Debayle.  
WRadio 96.9FM. Mexico. 
 
The Effects of Acute and Chronic Stress on the Immune System.       January 2012 
Postgraduate Seminars in Immunology. 
National School of Biological Sciences.. Instituto Politécnico Nacional 
 
Breast Cancer Immunotherapy                   November 2011 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico 
 
Dynamis of Breast Cell Phsyiology             May 2011 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico  
 
Cellular Cycle of Mammary Gland Cells.            May 2011 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico  
 
Development and Involution of the Breast Gland.              May 2011 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico  
 
Advances in Breast Cancer Therapy                  September 2008 
International Diplomate in Breast Gland Pathology  





Breast Cancer Immunology                 November 2007 
Advanced Course in Breast Gland Pathology  
Spanish Hospital, College of Gynecologists and Obstetricians. 
Mexico.  
 
Breast Cancer Immunology                  April 2007 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico  
 
Mechanisms Involved in Cell Proliferation                 April 2007 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico  
 
Breast Cancer Molecular Biology            March 2007 
1st Course in Breast Gland Pathology for General Practitioners.  
National Association of General Practitioners and Family Physicians. 
Mexico.  
 
Newborn Immunology         October 2006 
Clinical Session. Pediatrics Pavillion 
Mexico City General Hospital.  
 
Breast Cancer Molecular Biology and Pathology               April 2006 
International Course on Errors to Avoid in Breast Gland Pathology.  
Spanish Hospital, College of Gynecologists and Obstetricians.  
 
Dynamics of Breast Cell Physiology           October 2006 
International Diplomate in Breast Gland Pathology  
La Salle University. Pachuca, Mexico.  
 
Breast Cancer Immunology               July 2005 
International Course on Errors to Avoid in Breast Gland Pathology.  
Spanish Hospital, College of Gynecologists and Obstetricians  
Erupean Institute of Oncology. Milan, Italy  
 
Active immunization in Clinical Practice              June 2005 
2nd  Clinical Workshop for Interns  
Dalinde Medical Center. Mexico. 
 
The Mollecular Biology of Breast Cancer           April 2004 
XXV Annual Reunion of the College of  Gynecologists and Obstetricians 








Analysis of the cytokine pattern and other proteins            May 2000 
secreted by J-774 cells infected with tuberculosis complex bacteria. 
XV Latin-American Congress of Microbiology.  




Holistic Stress Management Instructor’s                 September 2011 
Certification Workshop  
Paramount Wellness Institute. American Holistic Nurses Association 
Boulder, Colorado 
 
Advanced Course in Basic And Clinical immunology             February 2010 
Federation of Clinical Immunology Societies 
Scottsdale, Arizona 
 
Theoretical-Practical Course in Flow Cytometry             December 2007 
Uses of Flow Cytometry in Clinical Biomedicine  
Clínica Ruiz. Dr. Alejandro Ruiz-Argüelles 
Puebla, Puebla. Mexico 
 
Theoretical- Practical Course in Proteomics                 October 2007 
Postgraduate and Research Department.  
Anáhuac University. In collaboration with BioRAD 
Huixquilucan, Mexico 
 
Basic Immunology for Clinicians Course: Update 2007          June 2007 
Interventional Immunology, Immunoassessment     
and Damage Associated Molecular Pattern Molecules Symposia     
Clinical Immunology Society 
San Diego, California 
 
Advanced Course in Mucosal Immunology                   October 2002 
Ruggero Ceppelini Superior School of Immunology 
Naples, Italy. 
 
Learning Evaluation Course                           September 2002 
Center for Teacher Development. Anáhuac University 
Huixquilucan, Estado de Mexico 
 
Advanced Trauma Life Support Course           March 1996 








V SLIMP/ IV Annual Reunion of the Latin American Chapter of the         February, 2013 
American Society for Reproductive Immunology. 
Iguaçu, Brazil. 
 
 XVII National Congress of Immunology              May 2006 
Mexican Immunology Society. Mexico  
 
International Fibromyalgia Symposium            May 2005 
American British Cowdray Medical Center. Mexico  
 
XV National Congress of Immunology           Abril  2002 
Mexican Immunology Society. Mexico  
 
XIV Annual Reunion of the National Institute of Perinatology        April 1997 
National Institute of Perinatology. Mexico 
 
Vaccines and Immunizations in the Pediatric Population          April 1997 
Mexican Pediatrics Society 
 
1st World Congress of Pediatric Infectious Diseases                  December 1996 
World Society of Pediatric Infectious Diseases 
 
1er International Congress of Human Breastfeeding   




Mucosal Immunology Course Scholarship                 October 2002 
Ruggero Ceppelini Superior School of Immunology 
Naples, Italy. 
 
Scholarship for Master of Science studies           1997 
National Council of Science and Technology (CONACyT). Mexico 
 
HONORS AND AWARDS 
 
Psi Chi Member. International Honor Society in Psychology     August 2011 
 





Excellence in Teaching Award. Anáhuac University           May 2009 
 
Excellence in Teaching Award. Anáhuac University           May 2008 
 
Excellence in Teaching Award. Anáhuac University           May 2007 
 
Excellence in Teaching Award. Anáhuac University           May 2006 
 
Excellence in Teaching Award. Anáhuac University           May 2005 
 
Synodal Award . Anáhuac University                April 2005 
 
Synodal Award . Anáhuac University              July 2004 
 
Excellence in Teaching Award. Anáhuac University            May 2005 
 
Synodal Award . Anáhuac University          January2004 
 
Synodal Award . Anáhuac University              July 2003 
 
Excellence in Teaching Award. Anáhuac University           May 2003 
 
Award for having achieved the highest grade             July 1996 
in the Intern Graduate Program.   
Spanish Hospital. Mexico 
 
Medical Doctorate Professional Oral Exam of exceptional quality           July 1996 
Universidad Nacional Autónoma de Mexico 
 
Medical Doctorate Written Professional Exam of excellent quality                   July 1996  
Anáhuac University 
 
Suma cum laude. Medical Doctorate              July 1996 
Universidad Anáhuac / UNAM 
 
3rd Place in the National Exam of Primary Education.          June 1985 





Member. Clinical Immunology Society (CIS)          2007 - Present 
 




for the Advancement of Science  (AAAS)   
 
Member. Health Psychology Division of the American         2009 - Present 
Psychological Association (APA, Division 38). 
 
Member. Psychoneuroimmunology Research Society        2011 – Present 
 
Member. Federation of Clinical Immunology Societies            2011 – Present 
 
Member. Latin American Society for Immunodeficiencies             2011 - Present 
 
Member. Psi Chi, International Honor Society in Psychology        2011- Present 
 




Certificate of Proficiency in English (CPE)               June 1990 
Cambridge University. Cambridge. England 
 
First Certificate in English              June 1989 
Cambridge University. Cambridge, England 
 
Diplôme de la Langue Française.                 June 1988  
Federation des Alliances Françaises 
Mexico 
 
French Language Intermediate Level Certificate              June 1986 





Experience with Windows and Mac operating systems  
Experience with Microsoft Office software for Windows and MAC: Word, Excel Power 
Point. 
Experience with iWork software for MAC:  Pages, Keynote. 
Experience as teacher and student with programs for online education: eCollege, 
Blackboard, Moodle. 
Experience with Refworks, Zotero and End Note reference software, and IBM SPSS 









I do community service with the SERTULL Foundation in Mexico, participating in the 
Health Promotion and the Human Rights Committees. 
The Human Rights Committee collaborates with institutions dedicated to combat human 
trafficking and commercial sexual exploitation in Mexico.   
 
 
